k99_581_2	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	28.9	180	313	343	8.49e-13	67.0
k99_581_2	NCBI|WP_063856710.1|1|1|vanH-Pt2|vanH-Pt2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Pt2|AMR|glycopeptide	28.3	180	313	322	1.85e-12	65.9
k99_581_2	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	29.1	182	313	348	2.12e-12	65.9
k99_581_2	SARG|NP_878015	29.8	178	313	322	2.49e-12	65.5
k99_581_2	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	31.4	121	313	314	7.83e-12	63.9
k99_587_2	NCBI|WP_002382867.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	30.3	231	432	447	6.82e-23	99.4
k99_587_2	NCBI|WP_012579101.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	30.3	231	432	447	6.82e-23	99.4
k99_587_2	NCBI|WP_063856739.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	30.3	231	432	447	6.82e-23	99.4
k99_587_2	NCBI|WP_063856751.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	31.0	226	432	454	2.38e-22	97.8
k99_587_2	CARD|gb|ABD30512.1|ARO:3000839|arlS	28.3	258	432	451	5.71e-22	96.7
k99_587_2	NCBI|WP_002368696.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	29.4	231	432	447	1.83e-21	95.1
k99_587_2	NCBI|WP_063856741.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	25.8	264	432	386	1.69e-20	91.7
k99_587_2	megares|MEG_7488|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	25.8	264	432	386	1.69e-20	91.7
k99_587_2	NCBI|WP_063856742.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	25.4	264	432	388	5.72e-20	90.1
k99_587_2	megares|MEG_7489|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	25.4	264	432	388	5.72e-20	90.1
k99_587_3	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	41.8	225	230	228	5.95e-51	164
k99_587_3	CARD|gb|ATC67679.1|ARO:3000838|arlR	36.8	220	230	219	4.14e-49	159
k99_587_3	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.5	232	230	232	4.82e-45	149
k99_587_3	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.1	232	230	232	1.36e-44	148
k99_587_3	CARD|gb|AAD51348.1|ARO:3003066|smeR	38.1	223	230	229	1.77e-44	147
k99_587_3	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	34.2	228	230	231	2.64e-44	147
k99_587_3	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	230	231	1.48e-43	145
k99_587_3	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	230	231	1.48e-43	145
k99_587_3	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	36.8	223	230	225	3.53e-43	144
k99_587_3	CARD|gb|AAC73788.1|ARO:3003841|kdpE	36.8	223	230	225	3.53e-43	144
k99_669_2	CARD|gb|AEX49906.1|ARO:3003583|basS	28.4	292	475	477	1.02e-20	93.6
k99_669_3	CARD|gb|AAD51348.1|ARO:3003066|smeR	45.2	221	230	229	1.43e-57	181
k99_669_3	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	43.2	220	230	225	8.85e-47	153
k99_669_3	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	36.0	222	230	228	2.42e-44	147
k99_669_3	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.4	227	230	232	1.70e-42	142
k99_669_3	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.4	227	230	232	1.70e-42	142
k99_669_3	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	37.6	226	230	231	5.18e-41	139
k99_669_3	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	34.3	230	230	233	3.05e-40	137
k99_669_3	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	34.6	234	230	235	9.03e-40	135
k99_669_3	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	33.9	233	230	232	2.34e-39	134
k99_669_3	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	32.8	232	230	231	9.00e-39	133
k99_669_5	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	60.6	104	290	138	5.03e-39	132
k99_669_5	CARD|gb|BAA15221.2|ARO:3000263|marA	50.5	101	290	127	2.29e-29	107
k99_669_5	CARD|gb|AFK13828.1|ARO:3000823|ramA	48.0	102	290	124	1.73e-27	102
k99_669_10	SARG|gb|APB03219.1|ARO:3003986|TaeA	40.1	509	556	648	5.61e-115	354
k99_669_10	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	536	556	655	1.40e-66	227
k99_669_10	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	532	556	655	1.40e-66	227
k99_669_10	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	536	556	655	1.40e-66	227
k99_669_10	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	536	556	655	2.70e-66	226
k99_669_10	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	536	556	655	2.70e-66	226
k99_669_10	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	536	556	655	2.70e-66	226
k99_669_10	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	536	556	655	2.70e-66	226
k99_669_10	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.3	536	556	655	2.70e-66	226
k99_669_10	SARG|gb|AKA86814|ARO:3003746|optrA	31.3	536	556	655	2.70e-66	226
k99_1182_7	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	35.3	224	224	225	3.20e-39	134
k99_1182_7	CARD|gb|AAC73788.1|ARO:3003841|kdpE	35.3	224	224	225	3.20e-39	134
k99_1182_7	CARD|gb|ATC67679.1|ARO:3000838|arlR	31.7	218	224	219	3.22e-34	120
k99_1182_7	CARD|gb|AAG06465.1|ARO:3005063|cprR	32.9	219	224	223	2.57e-30	110
k99_1182_7	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	28.1	224	224	223	5.49e-29	107
k99_1182_7	CARD|gb|AAD51348.1|ARO:3003066|smeR	30.9	230	224	229	1.75e-28	106
k99_1182_7	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.5	226	224	219	1.95e-28	105
k99_1182_7	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	30.3	218	224	233	2.69e-28	105
k99_1182_7	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.5	226	224	219	2.73e-28	105
k99_1182_7	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.5	226	224	220	2.80e-28	105
k99_1182_11	SARG|gb|AAK76137.1|ARO:3000024|patA	28.7	230	379	564	1.91e-17	82.8
k99_1182_11	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	28.2	216	379	574	2.02e-13	70.5
k99_1182_11	SARG|gb|APB03219.1|ARO:3003986|TaeA	25.9	220	379	648	2.62e-09	57.8
k99_1182_21	SARG|AXF35727.1	26.0	204	234	497	1.25e-09	56.6
k99_1182_21	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	36.7	79	234	568	1.89e-08	53.1
k99_1182_21	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	40.7	81	234	550	4.55e-08	52.0
k99_1182_21	SARG|KC539823.1.gene1.p01	42.7	82	234	522	8.06e-08	51.2
k99_1182_21	SARG|AAG08983	36.5	85	234	524	1.08e-07	50.8
k99_1182_21	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	40.2	82	234	522	1.45e-07	50.4
k99_1182_21	NCBI|WP_032492560.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	40.2	82	234	522	2.62e-07	49.7
k99_1182_21	SARG|DQ823382.1.gene1.p01	40.2	82	234	522	2.62e-07	49.7
k99_1182_21	megares|MEG_7687|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	40.2	82	234	522	2.62e-07	49.7
k99_1182_21	megares|MEG_7686|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	40.2	82	234	522	2.62e-07	49.7
k99_1244_2	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	77.8	383	378	374	9.53e-213	586
k99_1244_2	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	55.3	369	378	357	7.96e-129	373
k99_1244_6	SARG|AAD41881	34.3	318	330	323	4.46e-60	194
k99_1244_6	SARG|AAD51059	34.0	318	330	323	3.50e-59	192
k99_1244_6	SARG|AAR37059	34.1	320	330	323	6.95e-59	191
k99_1244_6	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	33.6	318	330	323	9.79e-59	191
k99_1244_6	SARG|AAD42183	34.0	318	330	322	1.48e-57	187
k99_1244_6	SARG|gi|552942232|ref|WP_023043160.1|	32.7	318	330	323	3.02e-57	187
k99_1244_6	SARG|AY082011.1.gene6.p01	32.4	318	330	323	2.36e-56	184
k99_1244_6	SARG|KF478993.1.gene2.p01	35.2	290	330	350	5.27e-55	182
k99_1244_6	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	32.7	321	330	351	7.60e-55	181
k99_1244_6	SARG|gi|740152780|ref|WP_037997109.1|	32.2	320	330	322	5.49e-54	178
k99_1430_4	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	21.6	895	952	1033	1.09e-48	186
k99_1430_4	SARG|gb|AEY83581|ARO:3000510|mupB	21.6	895	952	1033	1.09e-48	186
k99_1430_4	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	22.5	892	952	1024	5.61e-47	181
k99_1430_4	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	22.5	892	952	1024	5.61e-47	181
k99_1430_4	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	22.5	892	952	1024	1.73e-46	179
k99_1430_4	SARG|gb|CAA53189|ARO:3000521|mupA	22.5	892	952	1024	1.73e-46	179
k99_1902_1	SARG|ZP_03048536	98.2	110	111	110	2.61e-77	222
k99_1902_1	SARG|NC_002695.1.913273.p01	97.3	110	111	110	3.71e-77	221
k99_1902_1	SARG|P23895	97.3	110	111	110	3.71e-77	221
k99_1902_1	SARG|gi|116668015|pdb|2I68|A	97.3	110	111	137	8.98e-77	221
k99_1902_1	SARG|ZP_04003442	97.3	110	111	117	1.90e-76	220
k99_1902_1	SARG|ABG69871	97.3	110	111	165	9.23e-76	220
k99_1902_1	SARG|YP_002398143	97.3	110	111	170	1.09e-75	220
k99_1902_1	SARG|gi|641684674|emb|CDN82496.1|	97.3	110	111	170	1.09e-75	220
k99_1902_1	SARG|AAN80811	97.3	110	111	170	1.09e-75	220
k99_1902_1	SARG|gi|643599925|ref|WP_025237077.1|	95.5	110	111	110	5.07e-75	216
k99_2437_4	SARG|gb|AEA37904.1|ARO:3003112|lsaC	26.8	209	242	492	8.95e-12	63.2
k99_2500_4	SARG|gi|895865878|ref|WP_048974758.1|	33.6	223	338	646	3.85e-28	114
k99_2500_4	SARG|gi|500194536|ref|WP_011867743.1|	29.9	214	338	306	2.19e-26	105
k99_2500_4	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	24.7	223	338	351	1.12e-12	67.0
k99_2500_4	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.3	224	338	351	1.51e-12	66.6
k99_2822_4	SARG|gb|AAS79458.1|ARO:3001302|chrB	36.4	242	270	280	3.08e-40	139
k99_2822_4	SARG|gb|AJD73064.1|ARO:3001301|RlmA(II)	33.2	241	270	282	1.12e-36	130
k99_2822_4	megares|MEG_4106|Drugs|MLS|23S_rRNA_methyltransferases|MYRA_1	32.3	260	270	295	1.22e-34	125
k99_2822_4	SARG|gb|BAA03674.1|ARO:3001300|myrA	32.3	260	270	295	1.22e-34	125
k99_2822_4	SARG|gb|CAB37345.2|ARO:3004592|erm(32)	31.4	245	270	280	7.40e-32	117
k99_2822_4	SARG|gb|AAD12162.1|ARO:3001299|tlrB	31.4	245	270	280	2.03e-31	116
k99_3766_1	CARD|gb|CAA79966.1|ARO:3003665|NmcR	27.7	238	281	295	3.18e-13	67.4
k99_3766_1	CARD|gb|VWQ00850.1|ARO:3003843|leuO	23.1	286	281	314	4.95e-13	67.0
k99_3766_5	SARG|AF139725.gene.p01	51.0	49	207	214	8.63e-11	58.2
k99_3766_5	SARG|AAF24171	51.0	49	207	214	8.63e-11	58.2
k99_3766_5	NCBI|WP_063856931.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	51.0	49	207	214	8.63e-11	58.2
k99_3766_5	NCBI|WP_063856932.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	51.0	49	207	214	8.63e-11	58.2
k99_3766_5	NCBI|WP_063856933.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	51.0	49	207	214	8.63e-11	58.2
k99_3766_5	NCBI|WP_063856934.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	51.0	49	207	214	8.63e-11	58.2
k99_3766_5	SARG|AAG21695	51.0	49	207	214	8.63e-11	58.2
k99_3766_5	SARG|AAK91782	51.0	49	207	214	8.63e-11	58.2
k99_3965_2	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.0	192	226	461	9.21e-08	50.8
k99_3965_2	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.0	192	226	461	9.80e-07	47.8
k99_3965_7	SARG|gi|835330218|ref|WP_047457825.1|	42.9	219	229	648	8.42e-56	187
k99_3965_7	SARG|YP_001453760	42.9	219	229	648	8.42e-56	187
k99_3965_7	SARG|gi|992390012|ref|WP_061077002.1|	42.9	219	229	648	1.17e-55	186
k99_3965_7	SARG|gi|754927849|ref|WP_042284850.1|	42.9	219	229	648	1.17e-55	186
k99_3965_7	SARG|gi|1017028727|ref|WP_063163394.1|	44.3	219	229	646	1.59e-55	186
k99_3965_7	SARG|gi|695731408|ref|WP_032657917.1|	44.3	219	229	646	2.21e-55	186
k99_3965_7	SARG|gi|896088003|ref|WP_049126277.1|	44.3	219	229	646	2.21e-55	186
k99_3965_7	SARG|gi|1028180030|ref|WP_063927084.1|	44.3	219	229	646	2.21e-55	186
k99_3965_7	SARG|gi|749017716|ref|WP_040076354.1|	43.8	219	229	646	2.21e-55	186
k99_3965_7	SARG|gi|798862580|ref|WP_045895455.1|	44.3	219	229	646	2.21e-55	186
k99_4142_9	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	45.3	232	240	252	2.13e-62	194
k99_4142_9	CARD|gb|AAG05188.1|ARO:3005068|ParR	41.6	231	240	235	7.78e-56	177
k99_4142_9	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	40.0	225	240	232	3.66e-53	170
k99_4142_9	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	40.0	225	240	232	3.66e-53	170
k99_4142_9	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	39.4	226	240	231	1.28e-50	164
k99_4142_9	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.4	226	240	231	1.28e-50	164
k99_4142_9	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.8	226	240	231	7.22e-50	162
k99_4142_9	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.8	226	240	231	1.02e-49	161
k99_4142_9	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.9	226	240	231	2.04e-49	160
k99_4142_9	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	39.5	228	240	225	9.67e-49	159
k99_4142_10	CARD|gb|BAB38260.1|ARO:3000830|cpxA	30.3	274	451	457	2.03e-34	132
k99_4466_4	SARG|gi|544923113|ref|WP_021332509.1|	32.6	384	555	478	8.51e-37	141
k99_4466_4	NCBI|WP_015031687.1|1|1|rox_sv|rox_sv||2|rifamycin|rifamycin|rifampin_monooxygenase_Rox|AMR|rifamycin	31.5	349	555	476	8.83e-28	115
k99_4466_4	SARG|gi|754504368|ref|WP_041915032.1|	28.1	338	555	378	2.66e-09	58.2
k99_4466_10	SARG|P42670	30.6	180	404	503	4.19e-07	50.8
k99_6119_14	SARG|ACB18769	100	394	395	394	2.15e-278	754
k99_6119_14	SARG|YP_312412	100	394	395	396	2.32e-278	754
k99_6119_14	SARG|YP_002331449	99.7	394	395	394	3.05e-278	753
k99_6119_14	SARG|ZP_02784870	99.7	394	395	394	3.05e-278	753
k99_6119_14	SARG|NC_002695.1.915420.p01	99.7	394	395	396	3.29e-278	753
k99_6119_14	SARG|NP_756458	99.7	394	395	396	3.29e-278	753
k99_6119_14	SARG|gi|291431185|gb|EFF04178.1|	99.7	394	395	396	9.43e-278	752
k99_6119_14	SARG|ABG71850	99.5	394	395	396	1.34e-277	752
k99_6119_14	SARG|YP_002393667	99.5	394	395	394	2.50e-277	751
k99_6119_14	SARG|YP_543187	99.5	394	395	396	2.70e-277	751
k99_7180_4	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	60.0	375	352	374	1.32e-156	443
k99_7180_4	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	52.1	359	352	357	1.33e-115	338
k99_7180_7	SARG|YP_001444376	67.1	152	153	154	2.23e-78	228
k99_7180_7	SARG|BAB59035	67.1	152	153	154	3.68e-77	225
k99_7180_7	SARG|BAC58936	64.5	152	153	154	7.43e-77	224
k99_7180_7	SARG|ZP_02197344	65.1	152	153	154	7.43e-77	224
k99_7180_7	SARG|YP_002666586	65.8	152	153	154	1.06e-76	224
k99_7180_7	SARG|Q8DF90	63.2	152	153	154	4.29e-76	222
k99_7180_7	SARG|ZP_00990220	63.2	152	153	154	1.23e-75	221
k99_7180_7	SARG|YP_002418004	63.2	152	153	154	1.74e-75	221
k99_7180_7	SARG|ZP_01813310	63.2	152	153	154	2.48e-75	220
k99_7679_1	CARD|gb|AIA35096.1|ARO:3005059|LptD	83.7	682	682	782	0.0	1187
k99_8586_13	SARG|gb|AAC74000.1|ARO:3003950|msbA	99.8	582	583	582	0.0	1093
k99_8586_13	SARG|gi|948137056|ref|WP_056795395.1|	33.7	579	583	602	1.77e-91	292
k99_8586_13	SARG|gi|1045390184|ref|WP_065479071.1|	33.2	570	583	605	2.68e-91	292
k99_8586_13	SARG|gi|928900436|ref|WP_053931243.1|	33.5	571	583	600	3.54e-90	289
k99_8586_13	SARG|gi|664579989|ref|WP_031094015.1|	33.5	571	583	601	3.63e-90	289
k99_8586_13	SARG|gi|695865802|ref|WP_032778631.1|	33.6	571	583	605	5.62e-90	288
k99_8586_13	SARG|gi|648667297|ref|WP_026359044.1|	32.6	570	583	605	1.55e-89	287
k99_8586_13	SARG|gi|764446018|ref|WP_044369325.1|	33.0	570	583	605	2.18e-89	287
k99_8586_13	SARG|gi|695842130|ref|WP_032755430.1|	33.0	570	583	603	2.90e-89	286
k99_8586_13	SARG|gi|664317010|ref|WP_030845774.1|	33.2	570	583	605	3.05e-89	286
k99_8586_26	NCBI|WP_184489348.1|1|1|blaPAM-5|blaPAM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_PAM-5|AMR|beta-lactam	37.5	88	216	287	1.15e-09	55.8
k99_8586_26	NCBI|WP_043245728.1|1|1|blaPAM-1|blaPAM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_PAM-1|AMR|beta-lactam	36.4	88	216	287	5.28e-09	53.9
k99_8586_26	NCBI|WP_420354156.1|1|1|blaPAM-6|blaPAM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_PAM-6|AMR|beta-lactam	36.4	88	216	287	5.28e-09	53.9
k99_8586_26	NCBI|WP_038576754.1|1|1|blaMIM-1|blaMIM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_MIM-1|AMR|beta-lactam	27.3	161	216	299	4.58e-08	51.2
k99_9538_3	SARG|AAY52004	30.1	276	325	322	1.63e-26	105
k99_9538_3	NCBI|WP_011029109.1|1|1|vanH-Sc|vanH-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Sc|AMR|glycopeptide	31.3	262	325	337	1.98e-25	103
k99_9538_3	SARG|KF478993.1.gene2.p01	34.7	199	325	350	2.38e-25	103
k99_9538_3	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	30.1	256	325	343	3.86e-24	99.8
k99_9538_3	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	30.1	256	325	348	4.13e-24	99.8
k99_9538_3	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	29.7	259	325	351	2.11e-23	97.8
k99_9538_3	megares|MEG_7399|Drugs|Glycopeptide|VanA-type_resistance_protein|VANHA_1	30.5	226	325	237	3.11e-23	95.1
k99_9538_3	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	27.1	247	325	314	8.81e-17	78.6
k99_10652_1	SARG|ZP_03064581	100	343	344	343	3.55e-233	635
k99_10652_1	SARG|gi|643436320|ref|WP_025210113.1|	99.7	343	344	343	5.04e-233	635
k99_10652_1	SARG|gi|935667920|ref|WP_054495375.1|	99.7	343	344	343	5.04e-233	635
k99_10652_1	SARG|gi|1016498541|ref|WP_063085435.1|	99.7	343	344	343	1.02e-232	634
k99_10652_1	SARG|YP_001726873	99.7	343	344	343	1.02e-232	634
k99_10652_1	SARG|YP_002295654	99.4	343	344	343	1.45e-232	634
k99_10652_1	SARG|gi|895860834|ref|WP_048971036.1|	99.7	343	344	343	1.45e-232	634
k99_10652_1	SARG|gi|984670524|ref|WP_060773951.1|	99.7	343	344	343	1.45e-232	634
k99_10652_1	SARG|gi|928855248|ref|WP_053901614.1|	99.4	343	344	343	1.45e-232	634
k99_10652_1	SARG|gi|510923351|ref|WP_016244136.1|	99.4	343	344	343	1.45e-232	634
k99_11471_3	SARG|gi|542061059|gb|ERI11611.1|	28.2	195	218	316	1.31e-16	75.9
k99_11471_3	SARG|gb|CDO61516.1|ARO:3003949|efrB	28.7	174	218	362	1.49e-09	55.8
k99_11471_3	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	27.2	162	218	579	3.88e-07	48.9
k99_11471_3	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	27.2	158	218	579	7.01e-07	48.1
k99_12017_2	SARG|gi|979588572|ref|WP_059340812.1|	31.8	314	286	343	2.87e-39	139
k99_12017_2	SARG|gi|984670524|ref|WP_060773951.1|	31.8	314	286	343	4.22e-38	136
k99_12017_2	SARG|gi|1027687821|ref|WP_063625584.1|	31.1	325	286	343	4.22e-38	136
k99_12017_2	SARG|gi|1020278005|ref|WP_063269009.1|	31.8	314	286	343	4.22e-38	136
k99_12017_2	SARG|gi|949798405|ref|WP_057108582.1|	31.8	314	286	343	4.22e-38	136
k99_12017_2	SARG|gi|754690819|ref|WP_042068768.1|	31.8	314	286	343	4.22e-38	136
k99_12017_2	SARG|YP_001460870	31.8	314	286	343	5.91e-38	135
k99_12017_2	SARG|NP_290715	31.5	314	286	343	8.27e-38	135
k99_12017_2	SARG|NP_709857	31.5	314	286	343	8.27e-38	135
k99_12017_2	SARG|YP_001465586	31.8	314	286	343	8.27e-38	135
k99_12231_11	CARD|gb|ALH22601.1|ARO:3000620|adeL	35.7	286	305	337	3.82e-46	157
k99_12990_9	SARG|gb|CDO61516.1|ARO:3003949|efrB	28.4	190	505	362	7.00e-13	68.9
k99_12990_9	SARG|gi|542061059|gb|ERI11611.1|	26.4	216	505	316	2.26e-10	60.8
k99_12990_9	SARG|gi|447057509|ref|WP_001134765.1|	25.0	208	505	309	6.85e-10	59.3
k99_12990_9	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	26.6	203	505	293	1.09e-09	58.5
k99_12990_9	SARG|gi|500194536|ref|WP_011867743.1|	25.8	209	505	306	2.14e-09	57.8
k99_12990_9	SARG|gi|488120365|ref|WP_002191762.1|	25.0	208	505	309	5.19e-09	56.6
k99_12990_9	SARG|gi|507050365|ref|WP_016121371.1|	24.5	208	505	309	5.19e-09	56.6
k99_12990_9	SARG|P42332	23.6	216	505	306	6.80e-09	56.2
k99_12990_9	SARG|ABB80128	23.6	216	505	306	6.80e-09	56.2
k99_12990_9	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	23.6	216	505	306	6.80e-09	56.2
k99_13513_11	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	45.3	106	286	138	4.63e-27	101
k99_13513_11	CARD|gb|BAA15221.2|ARO:3000263|marA	36.7	98	286	127	4.89e-18	77.4
k99_13513_11	NCBI|AAD44693.1|1|1|mtrA_Ngon|mtrA_Ngon||1|EFFLUX|EFFLUX|efflux_transporter_MtrCDE_transcriptional_activator_MtrA|AMR|efflux	26.5	102	286	301	7.75e-07	48.5
k99_13513_17	CARD|gb|CAA79966.1|ARO:3003665|NmcR	26.9	145	309	295	7.28e-11	60.8
k99_14003_4	SARG|ZP_03034990	99.6	457	458	457	0.0	867
k99_14003_4	SARG|gi|487415514|ref|WP_001682922.1|	99.3	457	458	457	0.0	867
k99_14003_4	SARG|YP_310429	99.3	457	458	457	0.0	867
k99_14003_4	SARG|gi|447097694|ref|WP_001174950.1|	99.3	457	458	457	0.0	867
k99_14003_4	SARG|gi|693048721|ref|WP_032218252.1|	99.3	457	458	457	0.0	867
k99_14003_4	SARG|gi|447097709|ref|WP_001174965.1|	99.3	457	458	457	0.0	866
k99_14003_4	SARG|gi|693104039|ref|WP_032258261.1|	99.3	457	458	457	0.0	866
k99_14003_4	SARG|gi|654659075|ref|WP_028119961.1|	99.3	457	458	457	0.0	866
k99_14003_4	SARG|B1LEM1	99.3	457	458	457	0.0	866
k99_14003_4	SARG|NC_002695.1.912329.p01	99.3	457	458	457	0.0	866
k99_14003_7	SARG|gb|ALV80601.1|ARO:3003801|bcr-1	35.8	232	404	402	1.05e-35	134
k99_14003_7	megares|MEG_8019|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	30.5	347	404	411	2.61e-31	122
k99_14003_7	NCBI|WP_011552636.1|1|1|cml_Myxo|cml_Myxo|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	30.5	347	404	411	2.61e-31	122
k99_14003_7	NCBI|WP_031633255.1|1|1|cmlA_floR|cmlA_floR|efflux|2|CHLORAMPHENICOL|PHENICOL|CmlA/FloR_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.3	341	404	395	1.41e-30	120
k99_14003_7	NCBI|WP_061345584.1|1|1|cml_Ochro|cml_Ochro|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.7	340	404	397	2.74e-30	119
k99_14003_7	NCBI|WP_115421099.1|1|1|cml_Ensi|cml_Ensi|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	28.8	344	404	400	1.02e-29	117
k99_14003_7	megares|MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	28.8	344	404	400	1.02e-29	117
k99_14003_7	SARG|gi|695688999|ref|WP_032634100.1|	26.1	329	404	404	2.03e-29	117
k99_14003_7	SARG|CP004022.1.gene3225.p01	26.1	341	404	394	1.19e-28	114
k99_14003_7	SARG|gi|730661043|ref|WP_034065992.1|	26.7	329	404	404	1.36e-28	114
k99_14003_11	NCBI|WP_063844229.1|1|1|cmlV|cmlV|efflux|2|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_MFS_transporter_CmlV|AMR|phenicol	35.1	387	390	412	7.49e-62	203
k99_14003_11	SARG|U09991.1.gene2.p01	35.1	387	390	436	1.35e-61	203
k99_14003_11	megares|MEG_1780|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	33.4	389	390	391	6.97e-50	171
k99_14003_11	SARG|AF015087.1.gene1.p01	33.6	387	390	391	1.37e-49	171
k99_14003_11	SARG|AF024666.2.gene33.p01	30.4	391	390	391	2.92e-47	164
k99_14003_11	SARG|gi|2708772|gb|AAB96371.1|	30.2	391	390	391	4.08e-47	164
k99_14003_11	SARG|YP_251195	30.4	391	390	391	5.70e-47	164
k99_14003_11	SARG|NP_044444	30.2	391	390	391	1.11e-46	163
k99_14003_11	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	32.5	354	390	391	1.55e-46	162
k99_14003_11	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	32.7	352	390	391	3.03e-46	162
k99_14003_17	SARG|gi|1005274230|ref|WP_061570074.1|	30.6	121	136	140	1.32e-07	46.6
k99_14003_17	SARG|Q9KBZ6	28.1	121	136	141	9.70e-07	44.3
k99_14359_4	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	35.2	568	591	579	3.35e-104	325
k99_14359_4	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	35.0	568	591	579	9.34e-104	324
k99_14359_4	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	31.7	562	591	574	8.82e-90	287
k99_14359_4	SARG|gb|AYV52072.1|ARO:3002882|lmrD	30.4	490	591	664	1.81e-63	219
k99_14359_4	SARG|gb|AAK76136.1|ARO:3000025|patB	29.4	487	591	588	1.62e-60	210
k99_14359_4	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	31.3	384	591	578	4.67e-46	170
k99_14359_4	SARG|gb|CDO61516.1|ARO:3003949|efrB	36.7	281	591	362	1.87e-44	160
k99_14359_5	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	34.5	579	594	579	1.62e-93	297
k99_14359_5	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	32.6	579	594	579	1.32e-86	279
k99_14359_5	SARG|gb|AAC74000.1|ARO:3003950|msbA	30.0	580	594	582	2.76e-71	239
k99_14359_5	SARG|gi|663330365|ref|WP_030329892.1|	28.6	573	594	607	2.53e-62	215
k99_14359_5	SARG|gi|928900436|ref|WP_053931243.1|	28.7	582	594	600	4.27e-62	214
k99_14359_5	SARG|gi|664579989|ref|WP_031094015.1|	28.7	582	594	601	4.36e-62	214
k99_14359_5	SARG|gi|663155409|ref|WP_030194633.1|	28.6	573	594	605	4.70e-62	214
k99_14359_5	SARG|gi|664538723|ref|WP_031054357.1|	28.6	573	594	605	4.70e-62	214
k99_14359_5	SARG|gi|664317010|ref|WP_030845774.1|	28.6	573	594	605	9.03e-62	214
k99_14359_5	SARG|gi|663286402|ref|WP_030292859.1|	28.6	573	594	605	9.03e-62	214
k99_15827_15	megares|MEG_8288|Drugs|beta-lactam|Mutant_porin_proteins|OMPA_1	84.8	356	351	374	2.96e-216	594
k99_15827_15	CARD|gb|CDO13836.1|ARO:3005044|OmpA	84.8	356	351	374	2.96e-216	594
k99_16176_5	SARG|WP_000345069.1	37.6	410	425	434	1.77e-81	256
k99_16764_1	SARG|YP_672169	99.3	683	684	683	0.0	1323
k99_16764_1	SARG|YP_002415222	99.1	683	684	683	0.0	1322
k99_16764_1	SARG|gi|545230555|ref|WP_021530214.1|	99.0	683	684	683	0.0	1321
k99_16764_1	SARG|YP_002410376	99.0	683	684	683	0.0	1321
k99_16764_1	SARG|gi|447197906|ref|WP_001275162.1|	99.0	683	684	683	0.0	1320
k99_16764_1	SARG|gi|545231255|ref|WP_021530875.1|	99.0	683	684	683	0.0	1319
k99_16764_1	SARG|gi|545277545|ref|WP_021564792.1|	98.8	683	684	683	0.0	1317
k99_16764_1	SARG|gi|545240861|ref|WP_021539663.1|	98.7	683	684	683	0.0	1316
k99_16764_1	SARG|gi|545272128|ref|WP_021561419.1|	98.7	683	684	683	0.0	1315
k99_16764_1	SARG|gi|545161961|ref|WP_021516817.1|	98.7	683	684	683	0.0	1314
k99_16764_2	SARG|gi|545250002|ref|WP_021548296.1|	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|gi|510912422|ref|WP_016233730.1|	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|gi|446533202|ref|WP_000610548.1|	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|ZP_03033545	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|YP_002394083	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|gi|446533244|ref|WP_000610590.1|	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|gi|485885800|ref|WP_001479705.1|	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|gi|693171998|ref|WP_032304306.1|	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|gi|545264457|ref|WP_021557437.1|	100	58	59	488	1.61e-33	117
k99_16764_2	SARG|gi|487376515|ref|WP_001649600.1|	100	58	59	488	1.61e-33	117
k99_16764_3	SARG|gi|486338705|ref|WP_001586568.1|	99.8	420	421	488	1.57e-287	782
k99_16764_3	SARG|gi|486309014|ref|WP_001577542.1|	99.3	420	421	488	9.04e-287	780
k99_16764_3	SARG|gi|446988020|ref|WP_001065276.1|	99.3	420	421	488	1.28e-286	780
k99_16764_3	SARG|YP_002415221	99.3	420	421	488	1.82e-286	779
k99_16764_3	SARG|gi|446533220|ref|WP_000610566.1|	99.3	420	421	488	2.59e-286	779
k99_16764_3	SARG|gi|545277544|ref|WP_021564791.1|	99.0	420	421	488	2.59e-286	779
k99_16764_3	SARG|gi|446533217|ref|WP_000610563.1|	99.3	420	421	488	3.68e-286	778
k99_16764_3	SARG|gi|693029425|ref|WP_032205244.1|	99.0	420	421	488	7.41e-286	778
k99_16764_3	SARG|gi|486158570|ref|WP_001522245.1|	98.8	420	421	488	7.41e-286	778
k99_16764_3	SARG|gi|446533219|ref|WP_000610565.1|	99.0	420	421	488	7.41e-286	778
k99_17731_4	megares|MEG_497|Drugs|beta-lactam|Class_C_betalactamases|ACT_1	53.2	77	175	77	3.14e-29	102
k99_18110_11	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	31.9	235	299	346	4.71e-20	87.8
k99_18464_1	SARG|M58472.1.gene1.p01	36.8	57	75	209	1.22e-10	53.5
k99_18464_1	SARG|AF015628.1.gene2.p01	41.1	56	75	212	4.64e-09	49.3
k99_18464_1	SARG|GQ205627.2.gene3.p01	35.8	53	75	216	9.15e-09	48.5
k99_19558_2	SARG|gi|500194536|ref|WP_011867743.1|	30.6	222	344	306	6.81e-28	109
k99_21159_4	SARG|ZP_04536687	99.8	493	494	506	0.0	916
k99_21159_4	SARG|YP_854844	99.8	493	494	495	0.0	916
k99_21159_4	SARG|ABG71110	99.8	493	494	493	0.0	916
k99_21159_4	SARG|gi|545156500|ref|WP_021511639.1|	99.6	493	494	493	0.0	915
k99_21159_4	SARG|gi|723116127|ref|WP_033560214.1|	99.6	493	494	493	0.0	915
k99_21159_4	SARG|gi|510918377|ref|WP_016239333.1|	99.6	493	494	493	0.0	915
k99_21159_4	SARG|gi|1020277983|ref|WP_063268995.1|	99.6	493	494	493	0.0	915
k99_21159_4	SARG|gi|754635104|ref|WP_042021575.1|	99.6	493	494	493	0.0	915
k99_21159_4	SARG|gi|545161615|ref|WP_021516476.1|	99.6	493	494	493	0.0	915
k99_21159_4	SARG|gi|765449509|ref|WP_044707202.1|	99.6	493	494	493	0.0	915
k99_22805_2	SARG|gb|APB03216.1|ARO:3003982|LlmA	32.1	112	655	287	1.16e-08	55.8
k99_22805_3	SARG|gb|AVI44920.1|ARO:3004470|poxtA	31.0	525	636	542	1.08e-70	237
k99_22805_3	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	31.0	525	636	544	1.13e-70	237
k99_22805_3	ResF|poxtA-Ef_1_WP094899500.1_1	30.2	523	636	538	2.72e-69	233
k99_22805_3	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	30.2	523	636	543	3.05e-69	233
k99_22805_3	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	30.2	523	636	543	3.05e-69	233
k99_22805_3	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.8	507	636	655	5.95e-67	230
k99_22805_3	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.8	507	636	655	1.14e-66	229
k99_22805_3	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.9	634	636	655	1.59e-66	229
k99_22805_3	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.6	507	636	655	2.20e-66	228
k99_22805_3	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.6	507	636	655	4.22e-66	228
k99_23226_20	SARG|gi|445996710|ref|WP_000074565.1|	30.3	228	507	309	4.23e-15	75.1
k99_23226_20	SARG|gi|445996719|ref|WP_000074574.1|	28.7	230	507	309	3.34e-14	72.4
k99_23226_20	SARG|gi|542061059|gb|ERI11611.1|	29.8	225	507	316	3.58e-14	72.4
k99_23226_20	SARG|gi|507044560|ref|WP_016115614.1|	30.5	243	507	306	4.35e-14	72.0
k99_23226_20	SARG|gi|445996722|ref|WP_000074577.1|	28.7	230	507	309	4.48e-14	72.0
k99_23226_20	SARG|gi|814314593|emb|CKF49145.1|	29.8	228	507	309	4.48e-14	72.0
k99_23226_20	SARG|gi|445996723|ref|WP_000074578.1|	28.7	230	507	309	6.02e-14	71.6
k99_23226_20	SARG|gi|446026113|ref|WP_000103968.1|	30.0	243	507	306	7.84e-14	71.2
k99_23226_20	SARG|gi|445996709|ref|WP_000074564.1|	29.8	228	507	309	8.07e-14	71.2
k99_23226_20	SARG|gi|895736250|emb|COF64653.1|	29.4	228	507	309	8.07e-14	71.2
k99_25083_5	CARD|gb|BAB36671.1|ARO:3000832|evgA	27.3	194	216	204	8.99e-22	87.8
k99_25083_5	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	33.0	115	216	228	1.37e-12	63.5
k99_25083_5	CARD|gb|ATC67679.1|ARO:3000838|arlR	31.7	205	216	219	2.00e-10	57.4
k99_25767_21	CARD|gb|BAA16344.1|ARO:3000491|acrD	99.8	1037	1038	1037	0.0	1964
k99_25767_21	CARD|gb|AAC73564.1|ARO:3000216|acrB	66.0	1036	1038	1049	0.0	1296
k99_25767_21	SARG|gi|447196024|ref|WP_001273280.1|	64.1	1032	1038	1037	0.0	1249
k99_25767_21	SARG|gi|817600095|ref|WP_046594084.1|	64.0	1032	1038	1037	0.0	1249
k99_25767_21	SARG|gi|487663012|ref|WP_001752778.1|	64.0	1032	1038	1037	0.0	1249
k99_25767_21	SARG|gi|817604860|ref|WP_046598079.1|	64.0	1032	1038	1037	0.0	1249
k99_25767_21	SARG|gi|817600173|ref|WP_046594139.1|	64.0	1032	1038	1037	0.0	1248
k99_25767_21	SARG|gi|817601660|ref|WP_046595348.1|	64.0	1032	1038	1037	0.0	1248
k99_25767_21	SARG|CP000647.1.gene3710.p01	64.0	1032	1038	1036	0.0	1243
k99_25767_21	SARG|gi|556290479|ref|WP_023291164.1|	64.1	1032	1038	1036	0.0	1241
k99_27340_9	SARG|A1A9W0	100	402	403	402	3.00e-289	782
k99_27340_9	SARG|gi|486650002|ref|WP_001619313.1|	99.8	402	403	402	4.26e-289	781
k99_27340_9	SARG|gi|545230805|ref|WP_021530443.1|	99.8	402	403	402	4.26e-289	781
k99_27340_9	SARG|gi|1015950384|ref|WP_062899171.1|	99.8	402	403	402	4.26e-289	781
k99_27340_9	SARG|YP_852164	100	402	403	412	4.38e-289	782
k99_27340_9	SARG|gi|486228847|ref|WP_001558958.1|	99.5	402	403	402	8.59e-289	781
k99_27340_9	SARG|gi|972408415|ref|WP_059040274.1|	99.8	402	403	402	8.59e-289	781
k99_27340_9	SARG|gi|928811857|ref|WP_053876925.1|	99.8	402	403	402	8.59e-289	781
k99_27340_9	SARG|gi|545248523|ref|WP_021546864.1|	99.8	402	403	402	8.59e-289	781
k99_27340_9	SARG|gi|823638138|ref|WP_047085160.1|	99.8	402	403	402	8.59e-289	781
k99_27340_21	CARD|gb|ABV18113.1|ARO:3001329|mdtG	99.8	408	409	408	1.32e-286	776
k99_27340_21	SARG|WP_000136147.1	45.2	387	409	399	2.30e-110	328
k99_27340_21	NCBI|EHE72460.1|1|1|pmrA|pmrA|efflux|1|quinolone|quinolone|multidrug_efflux_MFS_transporter_PmrA|AMR|quinolone	42.9	387	409	371	5.33e-99	298
k99_27340_21	SARG|gi|446964071|ref|WP_001041327.1|	24.2	385	409	388	6.96e-19	86.7
k99_27340_21	SARG|gi|514074859|ref|WP_016528694.1|	24.4	385	409	388	9.38e-19	86.3
k99_27340_21	SARG|gi|486852995|ref|WP_001622527.1|	24.4	385	409	388	1.26e-18	85.9
k99_27340_21	SARG|NC_007622.3793623.p01	24.2	363	409	388	2.30e-18	85.1
k99_27340_21	SARG|gi|446964073|ref|WP_001041329.1|	24.2	385	409	388	2.30e-18	85.1
k99_27340_21	SARG|gi|446964072|ref|WP_001041328.1|	24.2	363	409	388	3.09e-18	84.7
k99_27340_21	SARG|gi|930433773|ref|WP_054194603.1|	24.2	385	409	388	5.61e-18	84.0
k99_27503_8	SARG|gb|AAC75089.1|ARO:3003577|ugd	100	388	389	388	1.15e-279	756
k99_27621_15	CARD|gb|VWQ00850.1|ARO:3003843|leuO	26.1	272	318	314	4.04e-23	96.3
k99_27621_18	NCBI|WP_063856871.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	29.0	252	428	346	3.14e-15	75.5
k99_27621_18	NCBI|WP_063856854.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.5	295	428	356	4.73e-14	72.0
k99_27621_18	megares|MEG_7603|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	28.3	290	428	355	2.70e-13	69.7
k99_27621_18	SARG|BAE96115	28.3	290	428	355	2.70e-13	69.7
k99_27621_18	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.2	290	428	355	2.07e-12	67.0
k99_27621_18	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	27.2	290	428	355	2.07e-12	67.0
k99_27621_18	SARG|ACM47285	27.2	290	428	363	2.16e-12	67.0
k99_27621_18	NCBI|WP_049898469.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.5	295	428	356	8.84e-12	65.1
k99_27621_18	NCBI|WP_063856862.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.0	268	428	356	1.58e-11	64.3
k99_27621_18	megares|MEG_7604|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_2	30.5	200	428	209	2.29e-11	62.0
k99_27621_21	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	100	233	234	633	7.75e-174	491
k99_27868_5	SARG|YP_002411827	100	648	649	648	0.0	1227
k99_27868_5	SARG|gi|446110318|ref|WP_000188173.1|	99.8	648	649	648	0.0	1227
k99_27868_5	SARG|YP_002269553	99.7	648	649	648	0.0	1226
k99_27868_5	SARG|gi|446110294|ref|WP_000188149.1|	99.8	648	649	648	0.0	1226
k99_27868_5	SARG|gi|895949336|ref|WP_049036297.1|	99.8	648	649	648	0.0	1226
k99_27868_5	SARG|gi|754613988|ref|WP_042003386.1|	99.7	648	649	648	0.0	1225
k99_27868_5	SARG|gi|446110333|ref|WP_000188188.1|	99.7	648	649	648	0.0	1225
k99_27868_5	SARG|YP_002408235	99.7	648	649	648	0.0	1225
k99_27868_5	SARG|gi|921982900|ref|WP_053273667.1|	99.7	648	649	648	0.0	1225
k99_27868_5	SARG|ZP_03003741	99.7	648	649	648	0.0	1225
k99_27868_6	SARG|gi|446669107|ref|WP_000746453.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|485863445|ref|WP_001462366.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|446669106|ref|WP_000746452.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|1028099935|ref|WP_063856172.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|693170425|ref|WP_032302786.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|585355297|ref|WP_024236900.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|983456720|ref|WP_060617235.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|446669114|ref|WP_000746460.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|766602958|ref|WP_044782102.1|	100	69	70	371	1.04e-41	137
k99_27868_6	SARG|gi|446669093|ref|WP_000746439.1|	100	69	70	371	1.04e-41	137
k99_28021_18	SARG|gi|507086196|ref|WP_016156937.1|	29.6	206	238	648	9.72e-22	92.4
k99_28021_18	SARG|gi|922960663|ref|WP_053388845.1|	29.6	206	238	648	9.72e-22	92.4
k99_28021_18	SARG|gi|491270241|ref|WP_005128370.1|	29.1	206	238	648	2.42e-21	91.3
k99_28021_18	SARG|gi|740856590|ref|WP_038641842.1|	29.1	206	238	648	2.42e-21	91.3
k99_28021_18	SARG|gi|851902043|ref|WP_048212057.1|	29.1	206	238	648	2.42e-21	91.3
k99_28021_18	SARG|gi|992380339|ref|WP_061067665.1|	29.1	206	238	648	2.42e-21	91.3
k99_28021_18	SARG|gi|695840638|ref|WP_032753940.1|	29.4	211	238	646	3.28e-21	90.9
k99_28021_18	SARG|gi|757799695|ref|WP_043016897.1|	29.1	206	238	648	3.29e-21	90.9
k99_28021_18	SARG|gi|1045891604|ref|WP_065554100.1|	29.1	206	238	648	3.29e-21	90.9
k99_28021_18	SARG|gi|507082903|ref|WP_016153652.1|	29.1	206	238	648	3.29e-21	90.9
k99_28021_19	SARG|gb|AYV52072.1|ARO:3002882|lmrD	24.7	231	256	664	2.87e-12	65.1
k99_28021_19	SARG|gb|CDO61516.1|ARO:3003949|efrB	25.3	174	256	362	4.01e-11	61.2
k99_28021_19	SARG|gb|AAK76136.1|ARO:3000025|patB	20.9	225	256	588	3.59e-07	49.7
k99_28021_19	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	27.3	110	256	461	4.38e-07	49.3
k99_28021_19	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	26.4	110	256	461	1.05e-06	48.1
k99_28173_3	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	34.7	432	501	429	3.05e-79	253
k99_28173_6	CARD|gb|ATC67679.1|ARO:3000838|arlR	39.5	220	223	219	4.22e-41	138
k99_28173_6	CARD|gb|AAG06465.1|ARO:3005063|cprR	36.7	218	223	223	5.12e-37	128
k99_28173_6	NCBI|WP_011029105.1|1|1|vanR-Sc|vanR-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-Sc|AMR|glycopeptide	35.0	217	223	231	4.24e-34	120
k99_28173_6	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	35.0	223	223	225	1.02e-33	119
k99_28173_6	CARD|gb|AAC73788.1|ARO:3003841|kdpE	35.0	223	223	225	1.02e-33	119
k99_28173_6	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.6	218	223	228	1.54e-33	119
k99_28173_6	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	33.2	217	223	233	3.46e-33	118
k99_28173_6	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	35.4	226	223	229	4.42e-33	118
k99_28173_6	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	32.4	225	223	232	1.20e-29	109
k99_28173_6	CARD|gb|AAD51348.1|ARO:3003066|smeR	34.4	218	223	229	1.39e-26	101
k99_28173_7	SARG|gb|BAE78116.1|ARO:3003576|eptA	99.8	547	548	547	0.0	1084
k99_28173_7	NCBI|WP_181726036.1|1|1|mcr-8.5|mcr-8||2|||phosphoethanolamine--lipid_A_transferase_MCR-8.5|AMR|peptide	43.3	531	548	565	2.13e-146	432
k99_28173_7	NCBI|WP_072310976.1|1|1|mcr-8.2|mcr-8||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-8.2|AMR|peptide	43.1	531	548	565	1.70e-145	429
k99_28173_7	SARG|gb|AVX52225.1|ARO:3004516|MCR-8	43.1	531	548	565	3.40e-145	429
k99_28173_7	NCBI|WP_118860654.1|1|1|mcr-8.4|mcr-8||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-8.4|AMR|peptide	43.1	531	548	565	6.80e-145	428
k99_28173_7	NCBI|WP_094308975.1|1|1|mcr-3.22|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.22|AMR|peptide	41.1	496	548	541	1.27e-144	426
k99_28173_7	SARG|gb|AUN87920.1|ARO:3004500|MCR-3.11	41.1	496	548	541	1.80e-144	426
k99_28173_7	SARG|WP_065804663.1	41.1	496	548	541	2.54e-144	426
k99_28173_7	NCBI|WP_136512112.1|1|1|mcr-3.29|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.29|AMR|peptide	41.1	496	548	541	2.54e-144	426
k99_28173_7	NCBI|WP_150823497.1|1|1|mcr-8.3|mcr-8||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-8.3|AMR|peptide	42.9	531	548	565	2.72e-144	426
k99_28173_9	CARD|gb|BAE77778.1|ARO:3000508|gadX	36.8	193	254	274	6.40e-36	127
k99_28418_17	SARG|gb|BAH45481.1|ARO:3002815|clbB	33.7	344	385	343	2.56e-51	174
k99_28418_17	NCBI|WP_111690898.1|1|1|cfr(C)|cfr(C)|target_modification|2|CHLORAMPHENICOL/CLINDAMYCIN/FLORFENICOL/LINEZOLID/STREPTOGRAMIN/TIAMULIN|LINCOSAMIDE/OXAZOLIDINONE/PHENICOL/PLEUROMUTILIN/STREPTOGRAMIN|23S_rRNA_(adenine(2503)-C(8))-methyltransferase_Cfr(C)|AMR|multidrug	34.6	356	385	379	3.68e-48	166
k99_28418_17	megares|MEG_1680|Drugs|MLS|23S_rRNA_methyltransferases|CFR_1	34.3	356	385	416	2.26e-47	165
k99_28418_17	SARG|CP001581.1.gene3143.p01	31.4	341	385	344	4.93e-46	160
k99_28418_17	SARG|gb|BAD63613.1|ARO:3002816|clbC	31.0	345	385	350	4.44e-44	155
k99_28418_17	SARG|gb|CAL84423.1|ARO:3004146|cfrC	30.2	344	385	344	7.56e-44	154
k99_28418_17	SARG|VXQ21601.1	31.6	348	385	344	6.03e-41	146
k99_30343_1	megares|MEG_4054|Drugs|Cationic_antimicrobial_peptide|Defensin-resistant_mprF|MPRF_1	27.2	279	319	880	7.47e-13	68.2
k99_30343_1	SARG|gb|Q8FW76|ARO:3003772|Brucella	27.2	279	319	880	7.47e-13	68.2
k99_30343_7	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	40.8	228	518	343	3.57e-51	177
k99_30343_7	SARG|P42332	34.1	255	518	306	2.19e-43	155
k99_30343_7	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	34.1	255	518	306	2.19e-43	155
k99_30343_7	SARG|gi|510143239|gb|AGN36970.1|	34.1	255	518	313	2.61e-43	155
k99_30343_7	SARG|ABB80128	34.1	255	518	306	3.04e-43	154
k99_30343_7	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	35.7	224	518	307	1.16e-42	153
k99_30343_7	SARG|gi|445996719|ref|WP_000074574.1|	35.4	226	518	309	2.35e-42	152
k99_30343_7	SARG|gi|542061059|gb|ERI11611.1|	34.4	224	518	316	3.87e-42	152
k99_30343_7	SARG|gi|446026113|ref|WP_000103968.1|	35.1	222	518	306	2.17e-41	149
k99_30343_7	SARG|gi|507035724|ref|WP_016107411.1|	34.1	226	518	309	3.23e-41	149
k99_31140_33	SARG|gi|486338738|ref|WP_001586577.1|	100	377	378	377	5.53e-286	771
k99_31140_33	SARG|gi|485750734|ref|WP_001376670.1|	99.2	377	378	377	1.07e-283	766
k99_31140_33	SARG|gi|723119731|ref|WP_033561977.1|	98.9	377	378	377	4.36e-283	764
k99_31140_33	SARG|gi|727405086|ref|WP_033813722.1|	98.9	377	378	377	3.58e-282	762
k99_31140_33	SARG|gi|501622858|ref|WP_012602900.1|	98.9	377	378	377	1.03e-281	761
k99_31140_33	SARG|gi|486158681|ref|WP_001522354.1|	98.7	377	378	377	2.94e-281	759
k99_31140_33	SARG|gi|485674599|ref|WP_001315152.1|	98.4	377	378	377	4.18e-281	759
k99_31140_33	SARG|gi|895859193|ref|WP_048969621.1|	98.7	377	378	377	4.18e-281	759
k99_31140_33	SARG|AAZ85968	98.4	377	378	377	2.42e-280	757
k99_31140_33	SARG|gi|486202959|ref|WP_001550478.1|	98.1	377	378	377	9.84e-280	756
k99_31140_34	megares|MEG_497|Drugs|beta-lactam|Class_C_betalactamases|ACT_1	79.2	77	178	77	1.08e-40	131
k99_31140_35	SARG|gi|1044625135|gb|OCB99622.1|	45.7	105	106	163	8.46e-21	80.5
k99_31140_35	SARG|gi|489246603|ref|WP_003154767.1|	45.7	105	106	112	1.93e-20	78.2
k99_31140_35	SARG|gi|1036316000|gb|OAZ59366.1|	45.7	105	106	163	2.38e-20	79.3
k99_31140_35	SARG|gi|494649292|ref|WP_007407236.1|	45.7	105	106	112	2.73e-20	77.8
k99_31140_35	SARG|gi|307606148|emb|CBI42519.1|	44.8	105	106	163	3.36e-20	79.0
k99_31140_35	SARG|ABS73653	45.7	105	106	112	1.10e-19	76.3
k99_31140_35	SARG|gi|505052607|ref|WP_015239709.1|	44.8	105	106	112	1.55e-19	75.9
k99_31140_35	SARG|gi|452079515|emb|CCP21271.1|	44.8	105	106	169	6.02e-19	75.9
k99_31140_35	SARG|gi|503879533|ref|WP_014113527.1|	45.7	105	106	112	1.01e-17	71.2
k99_31140_35	SARG|gi|489311090|ref|WP_003218499.1|	45.7	105	106	112	1.01e-17	71.2
k99_32888_2	CARD|gb|AAL14439.1|ARO:3000774|adeA	24.3	317	408	396	7.06e-11	62.4
k99_32888_4	NCBI|AAD15665.1|1|1|tbtM|tbtM||1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_outer_membrane_channel_subunit_TbtM|AMR|efflux	43.7	465	461	476	6.36e-107	324
k99_32888_4	NCBI|AAY90615.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	42.9	459	461	486	2.70e-105	320
k99_32888_4	SARG|CAG34266	43.3	455	461	474	8.42e-104	316
k99_32888_4	SARG|CAC14596	43.0	461	461	466	2.64e-103	315
k99_32888_4	NCBI|WP_003152694.1|1|1|toprJ1|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ1|AMR|tetracycline	41.1	462	461	477	3.66e-103	315
k99_32888_4	NCBI|WP_088903432.1|1|1|toprJ2|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ2|AMR|tetracycline	41.1	462	461	477	3.66e-103	315
k99_32888_4	SARG|CAG34251	42.7	461	461	466	5.26e-103	314
k99_32888_4	SARG|YP_002706078	42.7	461	461	481	8.20e-103	314
k99_32888_4	SARG|gi|544780240|ref|WP_021203903.1|	42.5	461	461	461	3.59e-102	311
k99_32888_4	SARG|gb|BAM10414.1|ARO:3003039|oprA	42.5	461	461	467	1.21e-101	310
k99_32888_5	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.2	219	228	219	1.37e-49	160
k99_32888_5	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	41.1	224	228	228	6.39e-47	154
k99_32888_5	CARD|gb|AAG06465.1|ARO:3005063|cprR	38.2	220	228	223	2.49e-45	149
k99_32888_5	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.5	222	228	219	3.95e-43	144
k99_32888_5	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	219	1.57e-42	142
k99_32888_5	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	220	1.62e-42	142
k99_32888_5	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	220	1.62e-42	142
k99_32888_5	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	36.8	228	228	233	1.64e-42	142
k99_32888_5	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	220	2.28e-42	142
k99_32888_5	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	34.4	227	228	229	4.04e-39	134
k99_32899_2	SARG|gi|447057510|ref|WP_001134766.1|	28.8	229	511	309	5.43e-22	95.5
k99_32899_2	SARG|gi|507055561|ref|WP_016126482.1|	28.8	229	511	309	9.98e-22	94.7
k99_32899_2	SARG|gi|488120365|ref|WP_002191762.1|	28.4	229	511	309	1.35e-21	94.4
k99_32899_2	SARG|gi|488067981|ref|WP_002139378.1|	28.8	229	511	309	2.48e-21	93.6
k99_32899_2	SARG|gi|507023808|ref|WP_016095885.1|	28.8	229	511	309	2.48e-21	93.6
k99_32899_2	SARG|gi|487936534|ref|WP_002010000.1|	28.8	229	511	309	2.48e-21	93.6
k99_32899_2	SARG|gi|507050365|ref|WP_016121371.1|	28.4	229	511	309	4.55e-21	92.8
k99_32899_2	SARG|gi|488130770|ref|WP_002201978.1|	28.8	229	511	309	4.55e-21	92.8
k99_32899_2	SARG|gi|488053456|ref|WP_002124853.1|	28.4	229	511	309	8.33e-21	92.0
k99_32899_2	SARG|gi|488068784|ref|WP_002140181.1|	27.9	229	511	309	1.13e-20	91.7
k99_33285_5	CARD|gb|TKW44661.1|ARO:3005040|YajC	46.9	113	111	112	8.79e-28	97.1
k99_33854_7	SARG|Q83LR7	31.2	237	471	648	2.64e-16	80.5
k99_33854_7	SARG|gi|647325472|ref|WP_025760953.1|	31.2	237	471	648	2.64e-16	80.5
k99_33854_7	SARG|gi|647323678|ref|WP_025760497.1|	31.2	237	471	648	2.64e-16	80.5
k99_33854_7	SARG|gi|1035686596|ref|WP_064530178.1|	30.8	237	471	648	2.64e-16	80.5
k99_33854_7	SARG|gi|851928815|ref|WP_048221086.1|	30.8	237	471	648	4.65e-16	79.7
k99_33854_7	SARG|gi|780033092|ref|WP_045444768.1|	30.8	237	471	648	4.65e-16	79.7
k99_33854_7	SARG|gi|740856590|ref|WP_038641842.1|	30.4	237	471	648	6.17e-16	79.3
k99_33854_7	SARG|gi|835233765|ref|WP_047410073.1|	29.4	269	471	648	8.19e-16	79.0
k99_33854_7	SARG|gi|754964360|ref|WP_042320280.1|	29.4	245	471	648	8.19e-16	79.0
k99_33854_7	SARG|gi|446110305|ref|WP_000188160.1|	30.8	237	471	648	8.19e-16	79.0
k99_33887_4	SARG|gi|445996719|ref|WP_000074574.1|	30.5	203	252	309	9.54e-23	93.6
k99_33887_4	SARG|gi|500448961|gb|EOP61695.1|	32.0	203	252	306	1.27e-22	93.2
k99_33887_4	SARG|gi|446026113|ref|WP_000103968.1|	32.1	193	252	306	1.27e-22	93.2
k99_33887_4	SARG|gi|500465078|gb|EOP76697.1|	32.0	203	252	306	1.27e-22	93.2
k99_33887_4	SARG|gi|447195835|ref|WP_001273091.1|	31.0	203	252	306	2.43e-22	92.4
k99_33887_4	SARG|P42332	30.5	203	252	306	4.66e-22	91.7
k99_33887_4	SARG|gi|507044560|ref|WP_016115614.1|	31.6	193	252	306	4.66e-22	91.7
k99_33887_4	SARG|gi|447195836|ref|WP_001273092.1|	30.5	203	252	306	6.45e-22	91.3
k99_33887_4	SARG|gi|445996729|ref|WP_000074584.1|	30.0	203	252	309	6.73e-22	91.3
k99_33887_4	SARG|gi|1043490477|ref|WP_065382463.1|	30.0	203	252	309	6.73e-22	91.3
k99_36670_8	CARD|gb|AAK37618.1|ARO:3005008|TxR	40.8	316	439	318	4.93e-65	210
k99_36749_1	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	28.9	197	340	255	1.42e-21	91.3
k99_36749_1	SARG|gb|WP_104671188.1|ARO:3003948|efrA	28.0	200	340	575	2.26e-16	79.0
k99_36749_1	SARG|gb|APB03219.1|ARO:3003986|TaeA	23.3	210	340	648	2.57e-08	54.3
k99_36749_1	SARG|M80346.gene.p01	25.2	234	340	551	1.75e-07	51.6
k99_36749_1	megares|MEG_1491|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|CARA_1	25.2	234	340	551	1.75e-07	51.6
k99_36749_1	SARG|M57437.gene.p01	29.8	168	340	548	1.27e-06	48.9
k99_36749_1	SARG|X63451.gene.p01	34.8	89	340	550	9.20e-06	46.2
k99_36749_1	megares|MEG_6558|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SRMB_1	34.8	89	340	550	9.20e-06	46.2
k99_36749_6	SARG|gi|500448961|gb|EOP61695.1|	26.9	216	491	306	4.81e-10	59.7
k99_36749_6	SARG|gi|507044560|ref|WP_016115614.1|	24.6	207	491	306	3.65e-09	57.0
k99_36749_6	SARG|gi|500465078|gb|EOP76697.1|	26.4	216	491	306	3.65e-09	57.0
k99_36749_6	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	25.8	217	491	461	8.32e-09	56.6
k99_36749_6	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	25.7	218	491	307	8.75e-09	55.8
k99_36749_6	SARG|gi|542061059|gb|ERI11611.1|	23.3	210	491	316	9.21e-09	55.8
k99_36749_6	SARG|gi|447195835|ref|WP_001273091.1|	25.9	205	491	306	1.16e-08	55.5
k99_36749_6	SARG|gi|446026113|ref|WP_000103968.1|	24.6	207	491	306	1.55e-08	55.1
k99_36749_6	SARG|gi|500194536|ref|WP_011867743.1|	23.7	207	491	306	2.76e-08	54.3
k99_36749_6	SARG|gi|447195836|ref|WP_001273092.1|	25.4	205	491	306	2.76e-08	54.3
k99_37451_10	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	24.3	230	463	359	2.39e-08	54.7
k99_37451_11	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.1	317	442	318	4.46e-67	216
k99_38772_3	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.2	306	693	318	1.05e-66	221
k99_41443_12	SARG|gi|2708772|gb|AAB96371.1|	26.1	180	465	391	1.83e-06	48.9
k99_41443_12	SARG|YP_251195	24.9	177	465	391	2.43e-06	48.5
k99_41443_12	SARG|AF024666.2.gene33.p01	24.9	177	465	391	2.43e-06	48.5
k99_41443_12	SARG|NP_044444	24.9	177	465	391	3.22e-06	48.1
k99_41443_12	SARG|gb|AAF40764.1|ARO:3003962|farB	25.3	162	465	508	6.65e-06	47.4
k99_41443_12	SARG|gi|1006695136|ref|WP_061822033.1|	23.0	161	465	388	7.43e-06	47.0
k99_42975_7	SARG|gb|ADZ12699.1|ARO:3005091|RanA	34.5	206	270	258	2.66e-35	126
k99_42975_7	SARG|gb|AAK76136.1|ARO:3000025|patB	24.0	221	270	588	9.02e-15	72.8
k99_42975_7	SARG|gb|AGN74946|ARO:3003749|salA	41.4	58	270	541	3.05e-07	50.1
k99_42975_7	SARG|gi|488231473|ref|WP_002302681.1|	41.5	65	270	492	3.96e-06	46.6
k99_42975_7	SARG|gi|488216250|ref|WP_002287458.1|	41.5	65	270	492	3.96e-06	46.6
k99_42975_7	SARG|gi|488247627|ref|WP_002318835.1|	41.5	65	270	492	3.96e-06	46.6
k99_42975_7	SARG|AY004350.gene.p01	41.5	65	270	492	3.96e-06	46.6
k99_42975_13	SARG|gi|500194536|ref|WP_011867743.1|	31.0	210	242	306	3.66e-27	105
k99_42975_13	SARG|gb|AGN74946|ARO:3003749|salA	25.7	187	242	541	1.97e-09	56.2
k99_42975_13	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	25.4	197	242	505	3.67e-08	52.4
k99_42975_13	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	27.5	153	242	504	8.88e-08	51.2
k99_42975_13	SARG|gi|817536927|ref|WP_046586836.1|	21.4	196	242	492	1.23e-06	47.8
k99_43273_5	NCBI|WP_407792291.1|1|1|mcr-12.1|mcr-12||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-12.1|AMR|peptide	31.5	257	506	548	2.21e-19	90.1
k99_43273_5	SARG|gb|WP_001572373.1|ARO:3004684|MCR-9	22.9	449	506	539	6.63e-18	85.5
k99_43273_5	NCBI|QKF95689.1|1|1|mcr-9.3|mcr-9||1|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-9.3|AMR|peptide	22.9	449	506	539	6.63e-18	85.5
k99_43273_5	NCBI|MBO4175406.1|1|1|mcr-9.2|mcr-9||1|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-9.2|AMR|peptide	22.9	449	506	540	6.65e-18	85.5
k99_43273_5	NCBI|WP_094308975.1|1|1|mcr-3.22|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.22|AMR|peptide	24.2	433	506	541	8.33e-16	79.0
k99_43273_5	NCBI|WP_111273843.1|1|1|mcr-3.14|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.14|AMR|peptide	24.1	440	506	540	2.58e-15	77.4
k99_43273_5	SARG|gb|MBA2799562.1|ARO:3005221|mcr-3.41	23.5	439	506	540	2.58e-15	77.4
k99_43273_5	NCBI|WP_103252528.1|1|1|mcr-3.25|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.25|AMR|peptide	23.8	433	506	540	2.58e-15	77.4
k99_43273_5	SARG|gb|ATQ63376.1|ARO:3004504|MCR-3.10	23.8	433	506	541	2.58e-15	77.4
k99_43273_5	SARG|WP_065804663.1	24.0	433	506	541	2.58e-15	77.4
k99_43273_8	SARG|AUI09862.1	40.1	269	283	287	5.73e-63	199
k99_43273_8	SARG|AJ459418.gene.p01	35.1	259	283	263	8.48e-47	156
k99_43273_8	SARG|gi|970263436|ref|WP_058647620.1|	35.1	259	283	263	1.68e-46	155
k99_43273_8	SARG|gi|553729091|ref|WP_023063817.1|	33.2	259	283	271	5.84e-38	134
k99_43273_8	NCBI|WP_001043265.1|1|1|sul2|sul2|insensitivity|2|sulfonamide|sulfonamide|sulfonamide-resistant_dihydropteroate_synthase_Sul2|AMR|sulfonamide	33.2	259	283	271	8.20e-38	133
k99_43273_8	SARG|gi|485778844|ref|WP_001402002.1|	33.2	259	283	271	1.15e-37	133
k99_43273_8	SARG|gi|638947703|ref|WP_024439711.1|	33.2	259	283	271	1.62e-37	132
k99_43273_8	SARG|gi|503278284|ref|WP_013512945.1|	33.5	266	283	271	1.62e-37	132
k99_43273_8	SARG|gi|916164813|ref|WP_050960181.1|	33.2	259	283	271	1.62e-37	132
k99_43273_8	SARG|gi|486033774|ref|WP_001505252.1|	33.2	259	283	271	1.62e-37	132
k99_43739_11	CARD|gb|AAC76296.1|ARO:3000656|AcrS	98.2	220	221	220	3.32e-156	430
k99_43739_11	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	29.5	193	221	210	1.93e-24	95.1
k99_43739_11	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	29.5	193	221	210	2.70e-24	94.7
k99_43739_12	SARG|gb|AAC76297.1|ARO:3000499|acrE	99.2	385	386	385	1.42e-267	726
k99_43739_12	SARG|CAC35724	69.6	375	386	399	4.24e-182	510
k99_43739_12	SARG|gi|928884686|ref|WP_053919771.1|	68.0	388	386	397	1.07e-179	504
k99_43739_12	SARG|YP_001879173	68.3	388	386	409	1.15e-179	504
k99_43739_12	SARG|YP_002401592	68.0	388	386	397	1.51e-179	503
k99_43739_12	SARG|CAS07946	68.0	388	386	397	2.15e-179	503
k99_43739_12	SARG|NC_002695.1.914620.p01	68.0	388	386	397	2.15e-179	503
k99_43739_12	SARG|gi|928844224|ref|WP_053895298.1|	68.0	388	386	397	3.05e-179	503
k99_43739_12	SARG|gi|928821234|ref|WP_053881997.1|	68.0	388	386	397	3.05e-179	503
k99_43739_12	SARG|gi|1000938487|ref|WP_061182054.1|	68.0	388	386	397	3.05e-179	503
k99_43739_13	SARG|gb|AAC76298.1|ARO:3000502|acrF	99.4	642	646	1034	0.0	1185
k99_43739_13	SARG|gi|487663012|ref|WP_001752778.1|	92.7	642	646	1037	0.0	1120
k99_43739_13	SARG|gi|447196024|ref|WP_001273280.1|	92.7	642	646	1037	0.0	1119
k99_43739_13	SARG|gi|817600095|ref|WP_046594084.1|	92.5	642	646	1037	0.0	1117
k99_43739_13	SARG|gi|817600173|ref|WP_046594139.1|	92.5	642	646	1037	0.0	1117
k99_43739_13	SARG|gi|817604860|ref|WP_046598079.1|	92.4	642	646	1037	0.0	1114
k99_43739_13	SARG|gi|817601660|ref|WP_046595348.1|	92.4	642	646	1037	0.0	1113
k99_43739_13	SARG|gi|556290479|ref|WP_023291164.1|	89.4	642	646	1036	0.0	1077
k99_43739_13	SARG|CP000647.1.gene3710.p01	89.1	642	646	1036	0.0	1076
k99_43739_13	SARG|gi|496667122|ref|WP_009309612.1|	88.9	642	646	1036	0.0	1075
k99_43739_14	SARG|gb|AAC76298.1|ARO:3000502|acrF	99.2	383	384	1034	7.46e-258	726
k99_43739_14	SARG|gi|817601660|ref|WP_046595348.1|	84.1	378	384	1037	7.89e-215	616
k99_43739_14	SARG|gi|447196024|ref|WP_001273280.1|	84.1	378	384	1037	7.89e-215	616
k99_43739_14	SARG|gi|817604860|ref|WP_046598079.1|	84.1	378	384	1037	7.89e-215	616
k99_43739_14	SARG|CP000647.1.gene3710.p01	84.1	377	384	1036	1.53e-214	615
k99_43739_14	SARG|gi|694076105|ref|WP_032421853.1|	83.8	377	384	1036	2.17e-214	615
k99_43739_14	SARG|gi|556290479|ref|WP_023291164.1|	84.1	377	384	1036	3.07e-214	614
k99_43739_14	SARG|gi|496667122|ref|WP_009309612.1|	84.1	377	384	1036	3.07e-214	614
k99_43739_14	SARG|gi|817600095|ref|WP_046594084.1|	83.9	378	384	1037	3.16e-214	614
k99_43739_14	SARG|gi|817600173|ref|WP_046594139.1|	83.9	378	384	1037	8.92e-214	613
k99_45062_2	CARD|gb|AAD51348.1|ARO:3003066|smeR	57.7	222	241	229	1.04e-85	253
k99_45062_2	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	40.8	228	241	228	3.04e-51	165
k99_45062_2	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.8	227	241	231	1.89e-47	155
k99_45062_2	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.9	227	241	232	2.74e-47	155
k99_45062_2	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.9	227	241	232	2.74e-47	155
k99_45062_2	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.3	227	241	231	3.76e-47	155
k99_45062_2	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	38.3	227	241	231	1.06e-46	154
k99_45062_2	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.3	227	241	231	1.06e-46	154
k99_45062_2	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.3	227	241	231	1.06e-46	154
k99_45062_2	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	38.1	231	241	235	1.88e-45	150
k99_45062_3	CARD|gb|AAD51347.1|ARO:3003067|smeS	42.0	436	442	467	3.69e-104	316
k99_45062_3	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	25.9	216	442	359	8.57e-20	89.4
k99_45062_4	SARG|CP001918.1.gene3442.p01	77.2	237	240	457	7.04e-121	350
k99_45170_20	CARD|gb|BAB38260.1|ARO:3000830|cpxA	99.1	107	108	457	4.99e-71	217
k99_45170_20	CARD|gb|ADM92606.1|ARO:3000549|adeS	41.4	87	108	361	7.97e-19	78.6
k99_45170_20	CARD|gb|CYF42523.1|ARO:3004047|kdpD	31.8	85	108	885	3.33e-11	57.4
k99_45831_1	SARG|YP_001668663	32.1	424	413	1043	1.84e-49	179
k99_45831_1	SARG|gi|499256187|ref|WP_010953727.1|	33.0	424	413	1042	1.55e-48	176
k99_45831_1	SARG|YP_348488	30.4	424	413	1043	5.24e-48	174
k99_45831_1	SARG|gi|496339859|ref|WP_009049037.1|	31.5	428	413	1043	5.24e-48	174
k99_45831_1	SARG|gi|489226605|ref|WP_003134989.1|	31.2	426	413	1043	9.63e-48	174
k99_45831_1	SARG|gi|730701571|ref|WP_034074282.1|	31.2	426	413	1043	9.63e-48	174
k99_45831_1	SARG|gi|553760372|ref|WP_023092945.1|	31.2	426	413	1043	1.31e-47	173
k99_45831_1	SARG|gi|730231410|ref|WP_033937120.1|	31.2	426	413	1043	1.31e-47	173
k99_45831_1	SARG|gi|558688683|ref|WP_023518100.1|	31.2	426	413	1043	1.31e-47	173
k99_45831_1	SARG|gi|489253786|ref|WP_003161790.1|	31.2	426	413	1043	1.31e-47	173
k99_45831_2	SARG|gb|BAE06006.1|ARO:3003705|mexN	20.8	583	611	1036	2.37e-24	107
k99_45831_2	SARG|gi|940169821|gb|KPX83830.1|	21.3	620	611	1059	9.09e-19	89.7
k99_45831_2	SARG|ZP_03453095	20.1	592	611	1043	6.29e-18	87.0
k99_45831_2	SARG|AAC27754	20.1	592	611	1043	6.29e-18	87.0
k99_45831_2	SARG|ZP_01769103	20.1	592	611	1043	6.29e-18	87.0
k99_45831_2	SARG|YP_369007	20.2	600	611	1045	6.29e-18	87.0
k99_45831_2	SARG|gi|950554518|ref|WP_057427257.1|	20.9	618	611	1060	5.81e-17	84.0
k99_45831_2	SARG|YP_992987	19.9	592	611	1041	1.00e-16	83.2
k99_45831_2	SARG|ZP_02909221	20.0	599	611	1045	1.00e-16	83.2
k99_45831_2	SARG|YP_773413	20.2	599	611	1045	3.03e-16	81.6
k99_45831_5	megares|MEG_8662|Drugs|Metronidazole|rdxA_nitroimidazole_reductase|RDXA_1	29.6	159	218	210	1.55e-12	63.2
k99_45996_7	SARG|gi|922960663|ref|WP_053388845.1|	40.4	223	243	648	1.06e-37	138
k99_45996_7	SARG|gi|757799695|ref|WP_043016897.1|	40.4	223	243	648	1.46e-37	137
k99_45996_7	SARG|gi|1045891604|ref|WP_065554100.1|	40.4	223	243	648	1.46e-37	137
k99_45996_7	SARG|gi|507082903|ref|WP_016153652.1|	40.4	223	243	648	1.46e-37	137
k99_45996_7	SARG|gi|491270241|ref|WP_005128370.1|	39.4	231	243	648	2.00e-37	137
k99_45996_7	SARG|gi|835233765|ref|WP_047410073.1|	40.4	223	243	648	2.00e-37	137
k99_45996_7	SARG|gi|754951242|ref|WP_042307417.1|	40.4	223	243	648	2.00e-37	137
k99_45996_7	SARG|gi|851902043|ref|WP_048212057.1|	39.4	231	243	648	2.00e-37	137
k99_45996_7	SARG|gi|992380339|ref|WP_061067665.1|	39.4	231	243	648	2.00e-37	137
k99_45996_7	SARG|gi|493734654|ref|WP_006683876.1|	40.4	223	243	648	2.00e-37	137
k99_46674_10	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.7	214	533	318	3.11e-32	125
k99_46742_3	SARG|gi|671541568|ref|WP_031525212.1|	39.3	219	263	648	6.87e-34	128
k99_46742_3	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	31.0	258	263	255	1.28e-32	119
k99_46742_3	SARG|gi|746482713|ref|WP_039520502.1|	35.2	250	263	648	7.66e-30	116
k99_46742_3	SARG|gi|555268367|ref|WP_023249730.1|	35.2	250	263	648	7.66e-30	116
k99_46742_3	SARG|gi|1027935297|ref|WP_063809363.1|	35.2	250	263	648	7.66e-30	116
k99_46742_3	SARG|gi|555258323|ref|WP_023240896.1|	35.2	250	263	648	7.66e-30	116
k99_46742_3	SARG|gi|685236936|ref|WP_031605176.1|	35.2	250	263	648	1.04e-29	116
k99_46742_3	SARG|gi|959866458|ref|WP_058145168.1|	35.2	250	263	648	1.04e-29	116
k99_46742_3	SARG|gi|555246906|ref|WP_023230855.1|	35.2	250	263	648	1.42e-29	115
k99_46742_3	SARG|gi|554958661|ref|WP_023203683.1|	35.2	250	263	648	1.42e-29	115
k99_46742_11	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.2	225	253	343	1.05e-21	91.3
k99_46742_11	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	32.6	221	253	293	2.70e-20	86.7
k99_46742_11	SARG|gb|AAA26793|ARO:3003748|oleC	28.2	234	253	325	7.14e-19	83.2
k99_46742_11	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	28.2	234	253	325	9.81e-19	82.8
k99_46742_11	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	22.7	229	253	293	2.86e-13	67.0
k99_46742_11	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	26.6	233	253	351	2.04e-11	62.0
k99_46742_11	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.6	233	253	351	2.76e-11	61.6
k99_46742_12	SARG|gb|AAK76137.1|ARO:3000024|patA	27.8	205	227	564	2.17e-12	64.7
k99_46742_12	SARG|gi|817122037|ref|WP_046494699.1|	32.1	209	227	613	1.48e-10	59.3
k99_46742_12	SARG|gi|662175949|ref|WP_030118884.1|	31.0	213	227	605	2.68e-10	58.5
k99_46742_12	SARG|gi|663155409|ref|WP_030194633.1|	31.0	213	227	605	2.68e-10	58.5
k99_46742_12	SARG|gi|664538723|ref|WP_031054357.1|	31.0	213	227	605	2.68e-10	58.5
k99_46742_12	SARG|gi|663330365|ref|WP_030329892.1|	31.0	213	227	607	2.68e-10	58.5
k99_46742_12	SARG|gi|944009777|ref|WP_055601444.1|	30.5	210	227	628	2.71e-10	58.5
k99_46742_12	SARG|gi|926286457|ref|WP_053623344.1|	31.0	213	227	605	3.62e-10	58.2
k99_46742_12	SARG|gi|655401130|ref|WP_028800283.1|	30.3	185	227	599	4.86e-10	57.8
k99_46742_12	SARG|gi|516795764|ref|WP_018105258.1|	31.2	202	227	601	4.86e-10	57.8
k99_48238_5	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	27.6	210	497	429	9.72e-17	81.3
k99_49442_3	CARD|gb|BAE77778.1|ARO:3000508|gadX	39.4	193	251	274	3.87e-41	141
k99_49442_5	CARD|gb|ANK04027.1|ARO:3003838|gadW	35.9	237	250	242	1.22e-47	157
k99_49442_5	CARD|gb|BAE77778.1|ARO:3000508|gadX	40.2	132	250	274	7.31e-23	93.2
k99_49743_2	SARG|gb|AAC75314.1|ARO:3003578|pmrF	99.7	322	323	322	1.57e-230	627
k99_49743_3	SARG|gi|693163692|ref|WP_032298102.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|546183294|ref|WP_021823865.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|485773738|ref|WP_001397534.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|545288391|ref|WP_021571368.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|AAC75315	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|510921449|ref|WP_016242282.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|487365279|ref|WP_001639677.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|693074684|ref|WP_032237896.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|487367794|ref|WP_001641971.1|	100	126	127	660	1.93e-87	266
k99_49743_3	SARG|gi|446783020|ref|WP_000860276.1|	100	126	127	660	1.93e-87	266
k99_49743_4	SARG|gi|446783025|ref|WP_000860281.1|	99.8	526	527	660	0.0	1071
k99_49743_4	SARG|gi|486230724|ref|WP_001559497.1|	99.6	526	527	660	0.0	1069
k99_49743_4	SARG|gi|754613472|ref|WP_042002901.1|	99.6	526	527	660	0.0	1069
k99_49743_4	SARG|gi|446783023|ref|WP_000860279.1|	99.6	526	527	660	0.0	1069
k99_49743_4	SARG|gi|486392102|ref|WP_001603016.1|	99.6	526	527	660	0.0	1069
k99_49743_4	SARG|gi|486340299|ref|WP_001587252.1|	99.6	526	527	660	0.0	1068
k99_49743_4	SARG|gi|567972683|ref|WP_024044380.1|	99.4	526	527	660	0.0	1067
k99_49743_4	SARG|gi|735685540|ref|WP_034173220.1|	99.2	526	527	660	0.0	1067
k99_49743_4	SARG|gi|693226710|ref|WP_032340892.1|	99.4	526	527	660	0.0	1067
k99_49743_4	SARG|B7N5M0	99.4	526	527	660	0.0	1067
k99_49743_6	SARG|gb|CDO12042.1|ARO:3005053|ArnT	63.0	551	551	551	6.06e-250	695
k99_52300_8	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	44.6	1369	1343	1186	0.0	1061
k99_52300_8	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	44.6	1369	1343	1186	0.0	1061
k99_52300_8	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	44.4	1362	1343	1162	0.0	1038
k99_52717_16	SARG|gi|554685678|ref|WP_023185565.1|	32.9	237	530	648	6.24e-23	101
k99_52717_16	SARG|gi|923061916|ref|WP_053445667.1|	32.8	232	530	648	1.11e-22	100
k99_52717_16	SARG|YP_001571041	33.2	232	530	648	1.47e-22	100
k99_52717_16	SARG|gi|960873409|ref|WP_058345546.1|	33.2	232	530	648	1.47e-22	100
k99_52717_16	SARG|gi|555268367|ref|WP_023249730.1|	32.1	237	530	648	2.61e-22	99.8
k99_52717_16	SARG|gi|1027935297|ref|WP_063809363.1|	32.1	237	530	648	2.61e-22	99.8
k99_52717_16	SARG|gi|446048048|ref|WP_000125903.1|	33.2	232	530	648	3.47e-22	99.4
k99_52717_16	SARG|gi|959109145|ref|WP_058113944.1|	33.2	232	530	648	3.47e-22	99.4
k99_52717_16	SARG|gi|446048047|ref|WP_000125902.1|	33.2	232	530	648	3.47e-22	99.4
k99_52717_16	SARG|gi|779838942|ref|WP_045343641.1|	32.3	232	530	648	4.61e-22	99.0
k99_52717_18	SARG|gb|ALV80601.1|ARO:3003801|bcr-1	38.9	316	397	402	2.00e-65	213
k99_52717_18	SARG|AM296481.1.gene2.p01	29.2	408	397	421	9.51e-31	120
k99_52717_18	megares|MEG_1775|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLB_1	29.2	408	397	421	9.51e-31	120
k99_52717_18	SARG|AF313472.2.gene8.p01	28.9	394	397	419	3.30e-30	119
k99_52717_18	megares|MEG_1764|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	28.9	394	397	419	3.30e-30	119
k99_52717_18	megares|MEG_1766|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	28.9	394	397	419	6.22e-30	118
k99_52717_18	SARG|AY115475.1.gene4.p01	28.9	394	397	419	6.22e-30	118
k99_52717_18	SARG|YP_001338812	28.9	394	397	435	7.60e-30	118
k99_52717_18	SARG|ABK51578	28.9	394	397	437	7.78e-30	118
k99_52717_18	megares|MEG_1772|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	28.9	394	397	437	7.78e-30	118
k99_52972_1	SARG|gi|542061059|gb|ERI11611.1|	28.8	146	176	316	1.21e-12	63.5
k99_52972_1	SARG|gi|507055561|ref|WP_016126482.1|	30.4	138	176	309	1.60e-12	63.2
k99_52972_1	SARG|gi|445996709|ref|WP_000074564.1|	30.1	143	176	309	2.20e-12	62.8
k99_52972_1	SARG|gi|445996710|ref|WP_000074565.1|	30.1	143	176	309	2.20e-12	62.8
k99_52972_1	SARG|gi|814314593|emb|CKF49145.1|	30.1	143	176	309	2.20e-12	62.8
k99_52972_1	SARG|gi|445996723|ref|WP_000074578.1|	31.2	138	176	309	3.00e-12	62.4
k99_52972_1	SARG|gi|445996729|ref|WP_000074584.1|	29.4	143	176	309	4.11e-12	62.0
k99_52972_1	SARG|gi|445996722|ref|WP_000074577.1|	30.4	138	176	309	4.11e-12	62.0
k99_52972_1	SARG|gi|500194536|ref|WP_011867743.1|	29.0	138	176	306	7.58e-12	61.2
k99_52972_1	SARG|gi|445996719|ref|WP_000074574.1|	30.4	138	176	309	7.68e-12	61.2
k99_52972_6	SARG|CP001918.1.gene3442.p01	44.5	456	476	457	1.09e-121	362
k99_52972_6	SARG|gi|751932149|ref|WP_041146857.1|	33.2	407	476	512	2.01e-45	164
k99_52972_6	SARG|gi|506355393|ref|WP_015875112.1|	33.3	403	476	511	3.78e-45	164
k99_52972_6	SARG|gi|491038386|ref|WP_004900055.1|	33.0	403	476	512	5.31e-45	163
k99_52972_6	SARG|gi|757697366|ref|WP_042927333.1|	33.5	406	476	512	7.34e-45	163
k99_52972_6	SARG|gi|647264873|ref|WP_025712752.1|	33.0	403	476	513	7.46e-45	163
k99_52972_6	SARG|gi|694065628|ref|WP_032412110.1|	33.0	403	476	510	9.83e-45	162
k99_52972_6	SARG|gi|740647460|ref|WP_038432906.1|	33.0	403	476	511	9.98e-45	162
k99_52972_6	SARG|gi|895919844|ref|WP_049017006.1|	33.0	403	476	512	1.01e-44	162
k99_52972_6	SARG|gi|692126801|ref|WP_032082759.1|	32.2	413	476	512	1.01e-44	162
k99_52997_6	SARG|gi|740410309|ref|WP_038243756.1|	29.0	518	621	563	3.09e-46	171
k99_52997_6	SARG|ZP_04615639	28.9	512	621	543	4.28e-46	170
k99_52997_6	SARG|ZP_04631861	29.1	512	621	543	5.87e-46	169
k99_52997_6	SARG|YP_001007250	28.8	518	621	563	5.23e-45	167
k99_52997_6	SARG|ZP_04623897	28.7	512	621	543	7.29e-45	166
k99_52997_6	SARG|ZP_04635128	28.7	512	621	543	7.29e-45	166
k99_52997_6	SARG|gi|318604694|emb|CBY26192.1|	28.7	509	621	540	9.54e-45	166
k99_52997_6	SARG|ZP_04612557	29.0	511	621	543	1.37e-44	166
k99_52997_6	SARG|gi|544012122|gb|ERK10884.1|	29.0	534	621	541	1.82e-44	165
k99_52997_6	SARG|gi|1001786599|ref|WP_061324791.1|	28.2	517	621	563	1.83e-44	166
k99_52997_7	SARG|gb|AAA25550.1|ARO:3003105|dfrA3	51.3	160	197	162	1.83e-52	164
k99_52997_7	SARG|gb|ABO40886.1|ARO:3004645|dfrI	40.7	162	197	191	2.63e-40	134
k99_52997_7	NCBI|WP_434062363.1|1|1|dfrA53|dfrA53|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA53|AMR|diaminopyrimidine	41.9	160	197	166	1.02e-39	132
k99_52997_7	SARG|gb|CBL80435.1|ARO:3002869|dfrK	40.9	159	197	163	2.66e-39	131
k99_52997_7	NCBI|WP_031775848.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	40.9	159	197	163	2.66e-39	131
k99_52997_7	SARG|gb|BAE15963.1|ARO:3002868|dfrG	40.3	159	197	165	2.81e-39	131
k99_52997_7	NCBI|WP_012779617.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	40.9	159	197	163	1.06e-38	129
k99_52997_7	SARG|gb|ASF80997.1|ARO:3005164|dfrA35	41.0	139	197	170	6.65e-36	122
k99_52997_7	SARG|gb|AAA85213.1|ARO:3002866|dfrD	39.2	158	197	162	4.76e-34	117
k99_52997_7	megares|MEG_2575|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRD_1	39.2	158	197	162	4.76e-34	117
k99_52997_12	SARG|AY234334.1.orf0.gene.p01	24.2	260	274	281	6.86e-16	74.7
k99_52997_12	SARG|NC_007792.3912746.p01	29.1	182	274	244	1.92e-14	70.1
k99_52997_12	SARG|NP_040462	28.6	182	274	244	1.27e-13	67.8
k99_52997_12	SARG|P13978	28.6	182	274	244	1.73e-13	67.4
k99_52997_12	NCBI|WP_011276921.1|1|1|erm(C)|erm(C)|target_modification|2|CLINDAMYCIN/ERYTHROMYCIN/STREPTOGRAMIN_B/TYLOSIN|LINCOSAMIDE/MACROLIDE/STREPTOGRAMIN|23S_rRNA_(adenine(2058)-N(6))-methyltransferase_Erm(C)|AMR|multidrug	28.6	182	274	244	1.73e-13	67.4
k99_52997_12	SARG|gi|157058876|gb|ABV03165.1|	28.6	182	274	244	1.73e-13	67.4
k99_52997_12	SARG|NC_010686.6295746.p01	28.6	182	274	244	1.73e-13	67.4
k99_52997_12	SARG|gi|353127769|gb|AEQ67361.1|	28.6	182	274	244	1.73e-13	67.4
k99_52997_12	SARG|NC_007209.3523503.p01	28.6	182	274	244	1.73e-13	67.4
k99_52997_12	SARG|gi|700659240|gb|AIU96746.1|	28.6	182	274	253	1.93e-13	67.4
k99_52997_15	CARD|gb|AIA35096.1|ARO:3005059|LptD	76.3	152	151	782	1.24e-76	241
k99_53122_5	SARG|AAR29485	24.9	450	539	639	2.70e-36	142
k99_53122_5	SARG|gi|672386269|gb|AIJ27535.1|	25.1	450	539	639	2.70e-36	142
k99_53122_5	SARG|gi|544707441|ref|WP_021137831.1|	24.9	450	539	639	2.70e-36	142
k99_53122_5	NCBI|WP_032490535.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	25.1	450	539	639	2.71e-33	133
k99_53122_5	megares|MEG_7165|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	24.1	448	539	639	2.71e-33	133
k99_53122_5	SARG|ZP_04668102	24.9	450	539	639	4.92e-33	132
k99_53122_5	SARG|AAY54279	24.9	450	539	639	1.20e-32	131
k99_53122_5	SARG|WP_002857791.1	24.9	450	539	639	1.62e-32	130
k99_53122_5	NCBI|WP_063856406.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	24.8	448	539	639	1.62e-32	130
k99_53122_5	SARG|AAW34142	24.7	450	539	639	1.62e-32	130
k99_54249_14	SARG|gb|CDO61516.1|ARO:3003949|efrB	25.1	179	309	362	3.42e-06	47.0
k99_54249_15	SARG|gi|491270241|ref|WP_005128370.1|	36.2	221	329	648	2.26e-23	99.8
k99_54249_15	SARG|gi|851902043|ref|WP_048212057.1|	36.2	221	329	648	2.26e-23	99.8
k99_54249_15	SARG|gi|992380339|ref|WP_061067665.1|	36.2	221	329	648	2.26e-23	99.8
k99_54249_15	SARG|gi|502669352|ref|WP_012905216.1|	34.2	237	329	648	3.05e-23	99.4
k99_54249_15	SARG|gi|851928815|ref|WP_048221086.1|	36.7	221	329	648	3.05e-23	99.4
k99_54249_15	SARG|gi|780033092|ref|WP_045444768.1|	36.7	221	329	648	3.05e-23	99.4
k99_54249_15	SARG|gi|757799695|ref|WP_043016897.1|	36.2	221	329	648	4.12e-23	99.0
k99_54249_15	SARG|gi|1045891604|ref|WP_065554100.1|	36.2	221	329	648	4.12e-23	99.0
k99_54249_15	SARG|gi|803568669|ref|WP_046077412.1|	33.8	219	329	648	4.12e-23	99.0
k99_54249_15	SARG|gi|507082903|ref|WP_016153652.1|	36.2	221	329	648	4.12e-23	99.0
k99_55851_1	CARD|gb|AAC75137.1|ARO:3000794|mdtC	99.4	512	513	1025	0.0	959
k99_55851_1	SARG|gb|AAG05914|ARO:3004075|MuxC	55.6	516	513	1036	1.40e-176	523
k99_55851_1	SARG|gb|AAG05915.1|ARO:3004074|MuxB	48.4	517	513	1043	1.89e-141	432
k99_55851_1	CARD|gb|AAC75136.1|ARO:3000793|mdtB	48.5	517	513	1040	3.76e-140	429
k99_55851_1	SARG|gb|BAE06006.1|ARO:3003705|mexN	45.9	516	513	1036	1.11e-127	396
k99_55851_1	SARG|CAW25151	27.7	527	513	1046	3.97e-43	163
k99_55851_1	SARG|gi|347302801|gb|AEO72915.1|	27.5	527	513	1033	2.35e-42	160
k99_55851_1	SARG|gi|552325898|gb|ERV85344.1|	27.5	527	513	918	2.78e-42	160
k99_55851_1	SARG|gi|504646765|ref|WP_014833867.1|	27.5	527	513	985	3.03e-42	160
k99_55851_1	SARG|gb|AAA74437.1|ARO:3000378|MexB	27.5	527	513	1046	3.19e-42	160
k99_55851_2	CARD|gb|AAC75137.1|ARO:3000794|mdtC	99.1	459	465	1025	2.86e-302	842
k99_55851_2	SARG|gb|AAG05914|ARO:3004075|MuxC	70.4	456	465	1036	1.46e-206	598
k99_55851_2	SARG|gb|AAG05915.1|ARO:3004074|MuxB	52.2	454	465	1043	1.28e-146	444
k99_55851_2	CARD|gb|AAC75136.1|ARO:3000793|mdtB	50.3	455	465	1040	3.20e-138	422
k99_55851_2	SARG|gb|BAE06006.1|ARO:3003705|mexN	50.1	451	465	1036	2.48e-131	404
k99_55851_2	SARG|gb|CAH14033.1|ARO:3004100|LpeB	34.7	464	465	1014	3.02e-76	256
k99_55851_2	SARG|gb|AAL19305.1|ARO:3000790|mdsB	36.7	469	465	1055	1.37e-73	249
k99_55851_2	SARG|YP_001116031	34.8	463	465	1066	7.32e-73	247
k99_55851_2	SARG|YP_371056	35.2	463	465	1066	7.32e-73	247
k99_55851_2	SARG|AAB58161	35.0	463	465	1027	1.03e-72	246
k99_55851_3	CARD|gb|AAC75136.1|ARO:3000793|mdtB	99.5	1040	1041	1040	0.0	1897
k99_55851_3	SARG|gb|AAG05915.1|ARO:3004074|MuxB	66.6	1026	1041	1043	0.0	1268
k99_55851_3	SARG|gb|AAG05914|ARO:3004075|MuxC	49.7	1019	1041	1036	2.67e-314	897
k99_55851_3	CARD|gb|AAC75137.1|ARO:3000794|mdtC	50.0	1025	1041	1025	1.69e-312	892
k99_55851_3	SARG|gb|BAE06006.1|ARO:3003705|mexN	49.5	1018	1041	1036	4.08e-308	881
k99_55851_3	CARD|gb|AAG07594.1|ARO:3000808|MexI	31.5	1013	1041	1029	1.05e-137	439
k99_55851_3	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	30.2	1053	1041	1074	4.77e-127	412
k99_55851_3	SARG|YP_350221	29.0	1007	1041	1009	6.22e-127	410
k99_55851_3	SARG|gb|AAL19305.1|ARO:3000790|mdsB	29.7	1058	1041	1055	2.32e-126	410
k99_55851_3	SARG|YP_001350280	29.5	1013	1041	1018	1.07e-125	407
k99_55851_4	CARD|gb|AAC75135.2|ARO:3000792|mdtA	99.5	415	416	415	6.64e-279	757
k99_55851_4	SARG|gb|AAG05916.1|ARO:3004073|MuxA	47.0	319	416	426	1.46e-91	281
k99_55851_4	SARG|gb|BAE06005.1|ARO:3003704|mexM	37.1	369	416	385	1.69e-68	221
k99_55851_4	SARG|gi|654292006|ref|WP_027806808.1|	32.5	332	416	405	5.84e-53	181
k99_55851_4	SARG|gi|691070849|ref|WP_032012412.1|	35.7	311	416	406	5.98e-53	181
k99_55851_4	SARG|YP_001778538	32.5	332	416	405	8.17e-53	180
k99_55851_4	SARG|ZP_02904981	32.8	332	416	405	3.13e-52	179
k99_55851_4	SARG|gi|491209910|ref|WP_005068241.1|	35.4	311	416	406	3.20e-52	179
k99_55851_4	SARG|gi|748187801|ref|WP_039758925.1|	35.4	311	416	406	3.20e-52	179
k99_55851_4	SARG|gi|727726402|ref|WP_033847639.1|	32.7	361	416	406	4.48e-52	178
k99_56126_6	SARG|AAA50325	33.5	164	206	569	2.28e-13	67.0
k99_56126_6	SARG|gi|514904648|ref|WP_016630030.1|	33.1	163	206	498	3.99e-13	66.2
k99_56126_6	SARG|gi|488306124|ref|WP_002376519.1|	33.1	163	206	498	9.93e-13	65.1
k99_56126_6	SARG|gi|895818174|ref|WP_048942695.1|	33.1	163	206	498	9.93e-13	65.1
k99_56126_6	SARG|gi|498528849|ref|WP_010828356.1|	32.5	163	206	498	9.93e-13	65.1
k99_56126_6	SARG|ZP_04433622	33.1	163	206	498	9.93e-13	65.1
k99_56126_6	SARG|gi|488327681|ref|WP_002397066.1|	33.1	163	206	498	9.93e-13	65.1
k99_56126_6	SARG|gi|498424272|ref|WP_010730861.1|	33.1	163	206	498	1.34e-12	64.7
k99_56126_6	SARG|gi|498517610|ref|WP_010817605.1|	33.1	163	206	498	1.34e-12	64.7
k99_56126_6	SARG|gi|498519697|ref|WP_010819589.1|	33.1	163	206	498	1.34e-12	64.7
k99_56216_2	SARG|gb|AAG57600.1|ARO:3000318|mphB	45.8	131	137	158	8.99e-34	114
k99_58838_6	CARD|gb|BAB36671.1|ARO:3000832|evgA	23.8	206	217	204	1.15e-23	92.8
k99_58838_6	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.5	164	217	228	3.88e-13	65.1
k99_58838_6	CARD|gb|ATC67679.1|ARO:3000838|arlR	24.5	200	217	219	4.17e-11	59.3
k99_58838_6	CARD|gb|AAG05188.1|ARO:3005068|ParR	24.4	164	217	235	3.41e-08	51.2
k99_59350_15	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	27.6	217	299	346	5.10e-18	82.0
k99_61346_1	SARG|gi|1001786599|ref|WP_061324791.1|	81.6	548	559	563	1.58e-302	829
k99_61346_1	SARG|gi|896190680|ref|WP_049199932.1|	80.1	554	559	563	3.18e-302	828
k99_61346_1	SARG|YP_001477377	80.1	548	559	563	8.64e-300	822
k99_61346_1	SARG|YP_001007250	80.5	548	559	563	1.65e-297	816
k99_61346_1	SARG|ZP_04638974	80.5	548	559	563	9.52e-297	814
k99_61346_1	SARG|YP_001401994	79.7	548	559	563	7.40e-294	807
k99_61346_1	SARG|AAS61092	79.7	548	559	563	1.05e-293	806
k99_61346_1	SARG|gi|740410309|ref|WP_038243756.1|	78.6	548	559	563	6.05e-293	805
k99_61346_1	SARG|YP_001605795	79.6	548	559	562	3.90e-291	800
k99_61346_1	SARG|gi|544012122|gb|ERK10884.1|	80.0	526	559	541	1.46e-283	780
k99_61346_2	SARG|YP_001477378	79.3	386	407	406	2.02e-213	590
k99_61346_2	SARG|ZP_04621517	77.2	390	407	404	4.60e-207	574
k99_61346_2	SARG|ZP_04631862	77.7	390	407	404	9.26e-207	573
k99_61346_2	SARG|ZP_04612558	76.5	392	407	404	5.34e-206	572
k99_61346_2	SARG|ZP_04638972	74.5	404	407	404	7.58e-206	571
k99_61346_2	SARG|YP_001605796	77.5	386	407	404	7.58e-206	571
k99_61346_2	SARG|YP_001401993	77.2	386	407	404	2.17e-205	570
k99_61346_2	SARG|ZP_04623896	78.2	380	407	380	3.68e-205	568
k99_61346_2	SARG|YP_001871501	77.2	386	407	404	6.20e-205	569
k99_61346_2	SARG|AAC60781	73.2	388	407	410	4.47e-185	519
k99_61405_9	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	34.6	211	256	343	2.54e-19	84.7
k99_61405_9	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	32.5	206	256	574	1.12e-18	84.0
k99_61405_9	SARG|gi|953808775|ref|WP_058042812.1|	34.3	201	256	608	1.06e-16	78.2
k99_61405_9	SARG|gb|AAC74000.1|ARO:3003950|msbA	32.2	202	256	582	1.40e-16	77.8
k99_61405_9	SARG|AF170880.4.gene1.p01	32.8	201	256	615	8.73e-16	75.5
k99_61405_9	SARG|gi|558888514|ref|WP_023543283.1|	32.8	201	256	615	8.73e-16	75.5
k99_61405_9	SARG|gi|926286457|ref|WP_053623344.1|	31.8	201	256	605	1.17e-15	75.1
k99_61405_9	SARG|gi|764446018|ref|WP_044369325.1|	32.8	201	256	605	1.17e-15	75.1
k99_61405_9	SARG|gi|695865802|ref|WP_032778631.1|	32.8	201	256	605	1.17e-15	75.1
k99_61405_9	SARG|gi|662175949|ref|WP_030118884.1|	31.8	201	256	605	1.17e-15	75.1
k99_66180_9	SARG|gi|851922185|ref|WP_048218206.1|	34.9	229	309	648	2.08e-30	119
k99_66180_9	SARG|gi|696375069|ref|WP_032949617.1|	34.9	229	309	648	2.08e-30	119
k99_66180_9	SARG|gi|489127020|ref|WP_003036815.1|	34.9	229	309	648	2.08e-30	119
k99_66180_9	SARG|YP_002850060	34.9	229	309	648	5.23e-30	118
k99_66180_9	SARG|gi|949718947|ref|WP_057063453.1|	35.1	225	309	648	5.23e-30	118
k99_66180_9	SARG|gi|696368937|ref|WP_032943949.1|	34.9	229	309	648	7.10e-30	118
k99_66180_9	SARG|Q83LR7	38.2	207	309	648	7.10e-30	118
k99_66180_9	SARG|gi|851913025|ref|WP_048215946.1|	34.9	229	309	648	7.10e-30	118
k99_66180_9	SARG|gi|647325472|ref|WP_025760953.1|	38.2	207	309	648	7.10e-30	118
k99_66180_9	SARG|gi|647323678|ref|WP_025760497.1|	38.2	207	309	648	7.10e-30	118
k99_66180_14	NCBI|WP_049898469.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.6	261	311	356	3.08e-11	62.4
k99_66180_14	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.1	263	311	355	2.39e-10	59.7
k99_66180_14	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	28.1	263	311	355	2.39e-10	59.7
k99_66180_14	SARG|ACM47285	28.1	263	311	363	2.45e-10	59.7
k99_66180_18	CARD|gb|WMY66391.1|ARO:3007682|MdtQ	71.7	127	128	479	2.43e-52	170
k99_66180_18	SARG|gi|486419591|ref|WP_001612185.1|	41.5	123	128	488	9.23e-22	88.2
k99_66180_18	SARG|gi|545170365|ref|WP_021524792.1|	41.5	123	128	488	9.23e-22	88.2
k99_66180_18	SARG|ZP_03033545	40.7	123	128	488	2.37e-21	87.0
k99_66180_18	SARG|gi|693033640|ref|WP_032208687.1|	40.7	123	128	488	2.37e-21	87.0
k99_66180_18	SARG|gi|693076172|ref|WP_032239077.1|	40.7	123	128	488	3.24e-21	86.7
k99_66180_18	SARG|gi|554022400|gb|ESE68782.1|	45.2	124	128	484	4.40e-21	86.3
k99_66180_18	SARG|gi|692991107|ref|WP_032179343.1|	40.7	123	128	488	4.44e-21	86.3
k99_66180_18	SARG|gi|545250002|ref|WP_021548296.1|	40.7	123	128	488	6.07e-21	85.9
k99_66180_18	SARG|gi|446533202|ref|WP_000610548.1|	40.7	123	128	488	6.07e-21	85.9
k99_67506_4	CARD|gb|AAK37618.1|ARO:3005008|TxR	40.1	302	445	318	2.13e-72	229
k99_67506_4	CARD|gb|ATC67679.1|ARO:3000838|arlR	33.6	110	445	219	3.41e-12	64.7
k99_68155_4	CARD|gb|AAC73564.1|ARO:3000216|acrB	99.9	1049	1050	1049	0.0	1979
k99_68155_4	SARG|gi|447196024|ref|WP_001273280.1|	80.7	1038	1050	1037	0.0	1617
k99_68155_4	SARG|gi|817600095|ref|WP_046594084.1|	80.6	1038	1050	1037	0.0	1615
k99_68155_4	SARG|gi|487663012|ref|WP_001752778.1|	80.5	1038	1050	1037	0.0	1615
k99_68155_4	SARG|gi|817601660|ref|WP_046595348.1|	80.7	1038	1050	1037	0.0	1614
k99_68155_4	SARG|gi|817604860|ref|WP_046598079.1|	80.6	1038	1050	1037	0.0	1614
k99_68155_4	SARG|gi|817600173|ref|WP_046594139.1|	80.6	1038	1050	1037	0.0	1613
k99_68155_4	SARG|BAC77251	81.2	1047	1050	1051	0.0	1608
k99_68155_4	SARG|gi|694076105|ref|WP_032421853.1|	81.3	1038	1050	1036	0.0	1607
k99_68155_4	SARG|gi|496667122|ref|WP_009309612.1|	81.4	1038	1050	1036	0.0	1606
k99_68155_5	SARG|CAS07946	100	397	398	397	1.23e-274	744
k99_68155_5	SARG|ACB17731	100	397	398	409	1.94e-274	744
k99_68155_5	SARG|YP_002396538	99.7	397	398	397	3.53e-274	743
k99_68155_5	SARG|gi|1000938487|ref|WP_061182054.1|	99.7	397	398	397	5.02e-274	743
k99_68155_5	SARG|NC_002695.1.914620.p01	99.7	397	398	397	5.02e-274	743
k99_68155_5	SARG|YP_002269113	99.7	397	398	409	7.88e-274	743
k99_68155_5	SARG|YP_309461	99.5	397	398	397	1.44e-273	742
k99_68155_5	SARG|gi|928884686|ref|WP_053919771.1|	99.5	397	398	397	1.44e-273	742
k99_68155_5	SARG|gi|928821234|ref|WP_053881997.1|	99.5	397	398	397	2.04e-273	741
k99_68155_5	SARG|YP_001879173	99.5	397	398	409	2.26e-273	742
k99_68155_6	CARD|gb|AAC76296.1|ARO:3000656|AcrS	37.7	204	216	220	3.81e-37	128
k99_68155_6	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	34.6	208	216	210	2.22e-33	118
k99_68155_6	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	34.6	208	216	210	4.40e-33	117
k99_68642_10	megares|MEG_1180|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|ASMA_1	98.2	617	618	617	0.0	1174
k99_68642_10	megares|MEG_1179|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|ASMA_1	61.7	609	618	607	6.62e-271	753
k99_68913_4	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	26.6	357	357	366	1.39e-30	118
k99_68913_4	SARG|JF802084.2.gene3.p01	28.6	360	357	700	2.00e-30	121
k99_68913_4	megares|MEG_7535|Drugs|Glycopeptide|VanN-type_resistance_protein|VANTN_1	30.0	287	357	656	1.90e-24	103
k99_70465_5	CARD|gb|AAC75429.1|ARO:3000833|evgS	35.2	122	130	1197	7.39e-16	71.6
k99_70465_5	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	37.1	105	130	231	9.28e-12	58.9
k99_70690_3	CARD|gb|AAL19308.1|ARO:3000504|golS	36.4	129	142	154	3.98e-18	74.7
k99_70690_8	SARG|B1LLK9	31.1	302	316	660	1.36e-37	140
k99_70690_8	SARG|gi|446783041|ref|WP_000860297.1|	30.5	302	316	660	3.11e-36	136
k99_70690_8	SARG|gi|550713000|ref|WP_022645909.1|	30.5	302	316	660	3.11e-36	136
k99_70690_8	SARG|gi|487375894|ref|WP_001649055.1|	29.8	302	316	660	5.80e-36	135
k99_70690_8	SARG|gi|757799830|ref|WP_043017032.1|	30.5	302	316	660	7.93e-36	135
k99_70690_8	SARG|gi|507086291|ref|WP_016157032.1|	30.1	309	316	660	1.48e-35	134
k99_70690_8	SARG|gi|1002399350|ref|WP_061382108.1|	29.8	302	316	660	2.02e-35	134
k99_70690_8	SARG|gi|486422571|ref|WP_001613499.1|	29.8	302	316	660	2.02e-35	134
k99_70690_8	SARG|gi|693171092|ref|WP_032303433.1|	30.1	302	316	660	2.02e-35	134
k99_70690_8	SARG|B7NNT4	29.8	302	316	660	2.76e-35	134
k99_72801_11	SARG|gb|AAG57600.1|ARO:3000318|mphB	92.7	137	138	158	1.04e-89	256
k99_73351_3	CARD|gb|AAG05188.1|ARO:3005068|ParR	45.6	239	240	235	9.23e-68	207
k99_73351_3	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	39.1	235	240	252	9.31e-50	162
k99_73351_3	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	35.3	232	240	228	4.91e-37	129
k99_73351_3	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	29.8	235	240	225	9.98e-32	115
k99_73351_3	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.0	231	240	231	8.87e-31	112
k99_73351_3	CARD|gb|AAD51348.1|ARO:3003066|smeR	32.3	232	240	229	3.29e-30	111
k99_73351_3	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	30.7	231	240	231	2.82e-28	106
k99_73351_3	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	30.7	231	240	231	2.82e-28	106
k99_73351_3	CARD|gb|ADM92605.1|ARO:3000553|adeR	29.9	234	240	247	4.46e-26	100
k99_73351_4	SARG|gb|AAG05187.1|ARO:3005067|ParS	33.7	430	434	428	9.51e-67	218
k99_73351_4	CARD|gb|BAB38260.1|ARO:3000830|cpxA	32.8	299	434	457	7.05e-38	142
k99_73351_4	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	27.6	214	434	357	1.29e-17	82.8
k99_73351_4	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	27.6	214	434	357	1.29e-17	82.8
k99_74000_2	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	36.4	242	239	252	5.67e-48	157
k99_74000_2	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	36.1	227	239	229	5.83e-42	141
k99_74000_2	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	35.2	227	239	231	1.07e-39	135
k99_74000_2	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.8	227	239	231	1.07e-39	135
k99_74000_2	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.4	227	239	231	8.41e-39	133
k99_74000_2	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	33.9	230	239	239	1.46e-38	133
k99_74000_2	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	32.6	227	239	231	6.58e-38	131
k99_74000_2	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.6	227	239	231	6.58e-38	131
k99_74000_2	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	32.5	234	239	231	7.25e-37	128
k99_74000_2	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.3	226	239	228	1.87e-36	127
k99_75273_4	SARG|gi|486427070|ref|WP_001615120.1|	100	327	328	371	4.93e-222	607
k99_75273_4	SARG|gi|446669114|ref|WP_000746460.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|766602958|ref|WP_044782102.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|485879464|ref|WP_001475184.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|486191968|ref|WP_001544419.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|693114136|ref|WP_032265097.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|757742704|ref|WP_042966294.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|895859667|ref|WP_048970095.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|654673112|ref|WP_028132114.1|	99.7	327	328	371	8.15e-221	604
k99_75273_4	SARG|gi|446669115|ref|WP_000746461.1|	99.7	327	328	371	8.15e-221	604
k99_75627_2	SARG|gi|500448961|gb|EOP61695.1|	28.0	218	504	306	1.58e-19	88.2
k99_75627_2	SARG|gi|500465078|gb|EOP76697.1|	28.0	218	504	306	2.14e-19	87.8
k99_75627_2	SARG|gi|447195835|ref|WP_001273091.1|	29.6	216	504	306	1.75e-18	85.1
k99_75627_2	SARG|ZP_04081918	29.6	216	504	306	3.19e-18	84.3
k99_75627_2	SARG|gi|447195836|ref|WP_001273092.1|	29.6	216	504	306	3.19e-18	84.3
k99_75627_2	SARG|gi|542061059|gb|ERI11611.1|	25.5	231	504	316	9.61e-17	80.1
k99_75627_2	SARG|gi|488120365|ref|WP_002191762.1|	26.1	230	504	309	7.56e-15	74.3
k99_75627_2	SARG|gi|488068784|ref|WP_002140181.1|	26.5	226	504	309	2.46e-14	72.8
k99_75627_2	SARG|gi|500194536|ref|WP_011867743.1|	25.6	219	504	306	3.20e-14	72.4
k99_75627_2	SARG|gi|447057509|ref|WP_001134765.1|	27.0	226	504	309	3.30e-14	72.4
k99_75738_6	SARG|gi|500194536|ref|WP_011867743.1|	31.3	201	512	306	1.27e-15	76.6
k99_75738_6	SARG|gi|542061059|gb|ERI11611.1|	30.4	204	512	316	3.45e-15	75.5
k99_75738_6	SARG|gi|447195835|ref|WP_001273091.1|	30.4	204	512	306	3.29e-14	72.4
k99_75738_6	SARG|gi|500465078|gb|EOP76697.1|	29.3	205	512	306	4.42e-14	72.0
k99_75738_6	SARG|gi|447195836|ref|WP_001273092.1|	30.4	204	512	306	4.42e-14	72.0
k99_75738_6	SARG|ZP_04081918	32.0	206	512	306	5.93e-14	71.6
k99_75738_6	SARG|gi|500448961|gb|EOP61695.1|	28.4	204	512	306	1.93e-13	70.1
k99_75738_6	SARG|gi|446026113|ref|WP_000103968.1|	26.7	202	512	306	3.47e-13	69.3
k99_75738_6	SARG|gb|AAK76137.1|ARO:3000024|patA	26.2	214	512	564	5.84e-13	70.1
k99_75738_6	SARG|gi|507044560|ref|WP_016115614.1|	26.7	202	512	306	1.50e-12	67.4
k99_77870_15	NCBI|WP_047693838.1|1|1|oqxA6|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA6|AMR|multidrug	38.5	161	311	391	6.24e-20	88.2
k99_77870_15	SARG|gb|AAP43109.1|ARO:3003922|oqxA	38.5	161	311	391	8.50e-20	87.8
k99_77870_15	NCBI|WP_004149398.1|1|1|oqxA10|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA10|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k99_77870_15	NCBI|WP_004212918.1|1|1|oqxA11|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA11|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k99_77870_15	NCBI|WP_063865373.1|1|1|oqxA5|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA5|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k99_77870_15	NCBI|WP_063865390.1|1|1|oqxA8|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA8|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k99_77870_15	NCBI|WP_063865399.1|1|1|oqxA9|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA9|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k99_77870_15	NCBI|WP_004890321.1|1|1|oqxA3|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA3|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k99_77870_15	NCBI|WP_063865358.1|1|1|oqxA2|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA2|AMR|multidrug	38.5	161	311	391	1.16e-19	87.4
k99_77870_15	NCBI|WP_063865368.1|1|1|oqxA4|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA4|AMR|multidrug	38.5	161	311	391	1.58e-19	87.0
k99_78414_3	CARD|gb|AAC75429.1|ARO:3000833|evgS	26.1	651	779	1197	1.16e-48	185
k99_78414_3	SARG|ZP_02848503	34.5	113	779	221	4.37e-08	53.5
k99_78414_3	CARD|gb|ATC67679.1|ARO:3000838|arlR	31.9	91	779	219	4.59e-07	50.4
k99_78414_3	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	33.7	92	779	225	6.96e-06	47.0
k99_78414_3	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	34.6	104	779	228	9.60e-06	46.6
k99_79536_3	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	32.6	221	243	325	9.45e-30	112
k99_79536_3	SARG|gb|AAA26793|ARO:3003748|oleC	32.9	219	243	325	1.84e-29	111
k99_79536_3	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.5	223	243	351	1.01e-13	68.6
k99_79536_3	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	26.5	223	243	351	1.86e-13	67.8
k99_80736_3	megares|MEG_8080|Drugs|Lipopeptide|Colistin_phosphoethanolamine_transferase|EPTB_1	81.4	553	564	574	0.0	931
k99_80736_3	SARG|gb|CCI79240.1|ARO:3005047|eptB	81.4	553	564	574	0.0	931
k99_80736_3	SARG|gb|BAE78116.1|ARO:3003576|eptA	25.2	540	564	547	1.52e-32	130
k99_80800_7	SARG|gi|1032819400|ref|WP_064325534.1|	31.0	252	338	646	2.16e-22	97.1
k99_80800_7	SARG|gi|779861244|ref|WP_045352062.1|	31.5	241	338	646	3.91e-22	96.3
k99_80800_7	SARG|gi|983405167|ref|WP_060572706.1|	31.1	238	338	646	5.27e-22	95.9
k99_80800_7	SARG|gi|782756348|ref|WP_045630015.1|	31.4	239	338	646	7.10e-22	95.5
k99_80800_7	SARG|gi|1022688710|ref|WP_063443532.1|	33.2	217	338	648	7.12e-22	95.5
k99_80800_7	SARG|gi|505180394|ref|WP_015367496.1|	33.2	217	338	648	7.12e-22	95.5
k99_80800_7	SARG|gi|851931792|ref|WP_048222288.1|	31.5	241	338	646	9.57e-22	95.1
k99_80800_7	SARG|gi|754493745|ref|WP_041910640.1|	31.0	239	338	646	9.57e-22	95.1
k99_80800_7	SARG|gi|798937928|ref|WP_045908399.1|	31.5	241	338	646	9.57e-22	95.1
k99_80800_7	SARG|gi|823326845|ref|WP_047080664.1|	33.2	217	338	648	9.59e-22	95.1
k99_80800_8	SARG|gi|447057509|ref|WP_001134765.1|	28.2	252	335	309	4.30e-21	90.9
k99_80800_8	SARG|gi|445996695|ref|WP_000074550.1|	28.2	216	335	309	1.11e-20	89.7
k99_80800_8	SARG|Q83LR7	30.8	224	335	648	1.33e-20	91.7
k99_80800_8	SARG|gi|647325472|ref|WP_025760953.1|	30.8	224	335	648	1.33e-20	91.7
k99_80800_8	SARG|gi|647323678|ref|WP_025760497.1|	30.8	224	335	648	1.33e-20	91.7
k99_80800_8	SARG|gi|488042066|ref|WP_002113463.1|	28.2	216	335	309	2.09e-20	89.0
k99_80800_8	SARG|gi|488120365|ref|WP_002191762.1|	28.5	214	335	309	2.86e-20	88.6
k99_80800_8	SARG|gi|445996698|ref|WP_000074553.1|	27.8	216	335	309	2.86e-20	88.6
k99_80800_8	SARG|gi|488068784|ref|WP_002140181.1|	28.0	214	335	309	2.86e-20	88.6
k99_80800_8	SARG|gi|488130770|ref|WP_002201978.1|	27.8	216	335	309	3.92e-20	88.2
k99_80828_2	CARD|gb|AAC75429.1|ARO:3000833|evgS	30.4	507	950	1197	8.20e-57	212
k99_80828_5	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	64.6	378	368	374	4.59e-166	468
k99_80828_5	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	51.0	363	368	357	2.70e-114	335
k99_80828_9	SARG|gb|AAC75271.1|ARO:3003952|yojI	99.5	547	548	547	0.0	1054
k99_80828_9	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	26.3	251	548	579	3.93e-13	70.9
k99_80828_9	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	26.0	262	548	579	5.20e-13	70.5
k99_80828_9	SARG|gb|AYV52072.1|ARO:3002882|lmrD	21.3	254	548	664	5.79e-13	70.5
k99_80828_9	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	25.6	227	548	578	3.67e-12	67.8
k99_84257_19	CARD|gb|CAA79966.1|ARO:3003665|NmcR	30.1	113	298	295	6.19e-07	48.9
k99_84621_9	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	29.1	127	350	397	8.65e-08	52.4
k99_84621_14	SARG|gi|504542119|ref|WP_014729221.1|	30.1	236	255	647	9.20e-12	63.5
k99_84621_14	SARG|gi|1045390184|ref|WP_065479071.1|	27.4	223	255	605	1.21e-11	63.2
k99_84621_14	SARG|gi|742378414|ref|WP_038857601.1|	30.0	233	255	647	1.24e-11	63.2
k99_84621_14	SARG|gi|497748188|ref|WP_010062372.1|	27.4	223	255	605	1.63e-11	62.8
k99_84621_14	SARG|gi|506220920|ref|WP_015740695.1|	30.3	218	255	647	2.24e-11	62.4
k99_84621_14	SARG|gi|764446018|ref|WP_044369325.1|	26.9	223	255	605	2.94e-11	62.0
k99_84621_14	SARG|YP_001438541	30.3	218	255	647	3.01e-11	62.0
k99_84621_14	SARG|gi|938461734|ref|WP_054625806.1|	30.3	218	255	647	3.01e-11	62.0
k99_84621_14	SARG|gi|938460528|ref|WP_054624864.1|	30.3	218	255	647	3.01e-11	62.0
k99_84621_14	SARG|gi|1020141879|ref|WP_063264839.1|	30.3	218	255	647	3.01e-11	62.0
k99_84621_15	SARG|gi|446048013|ref|WP_000125868.1|	31.9	254	269	648	2.02e-21	92.4
k99_84621_15	SARG|gb|AAK76137.1|ARO:3000024|patA	27.6	210	269	564	7.24e-17	79.0
k99_84621_15	SARG|gi|860594225|ref|WP_048475168.1|	29.1	220	269	620	7.30e-14	70.1
k99_84621_15	SARG|gi|496018010|ref|WP_008742581.1|	28.6	220	269	623	7.32e-14	70.1
k99_84621_15	SARG|gi|493394434|ref|WP_006350564.1|	26.7	236	269	602	3.19e-13	68.2
k99_84621_15	SARG|gi|695842130|ref|WP_032755430.1|	28.6	220	269	603	4.30e-13	67.8
k99_84621_15	SARG|gi|505420018|ref|WP_015607120.1|	28.6	220	269	603	4.30e-13	67.8
k99_84621_15	SARG|gi|926286457|ref|WP_053623344.1|	27.9	229	269	605	4.30e-13	67.8
k99_84621_15	SARG|gi|926400371|ref|WP_053728483.1|	28.8	219	269	603	7.78e-13	67.0
k99_84621_15	SARG|gi|764446018|ref|WP_044369325.1|	27.1	229	269	605	1.05e-12	66.6
k99_84639_3	NCBI|AAD44693.1|1|1|mtrA_Ngon|mtrA_Ngon||1|EFFLUX|EFFLUX|efflux_transporter_MtrCDE_transcriptional_activator_MtrA|AMR|efflux	34.6	81	393	301	3.26e-09	56.6
k99_84639_5	SARG|gi|491270241|ref|WP_005128370.1|	30.7	251	514	648	7.15e-21	95.1
k99_84639_5	SARG|gi|851902043|ref|WP_048212057.1|	31.3	233	514	648	1.26e-20	94.4
k99_84639_5	SARG|gi|992380339|ref|WP_061067665.1|	31.3	233	514	648	1.26e-20	94.4
k99_84639_5	SARG|gi|851928815|ref|WP_048221086.1|	31.3	233	514	648	1.26e-20	94.4
k99_84639_5	SARG|gi|780033092|ref|WP_045444768.1|	31.3	233	514	648	1.26e-20	94.4
k99_84639_5	SARG|gi|740856590|ref|WP_038641842.1|	30.9	233	514	648	3.95e-20	92.8
k99_84639_5	SARG|gi|507086196|ref|WP_016156937.1|	31.6	228	514	648	3.95e-20	92.8
k99_84639_5	SARG|gi|757799695|ref|WP_043016897.1|	30.9	233	514	648	6.97e-20	92.0
k99_84639_5	SARG|gi|1045891604|ref|WP_065554100.1|	30.9	233	514	648	6.97e-20	92.0
k99_84639_5	SARG|gi|507082903|ref|WP_016153652.1|	30.9	233	514	648	6.97e-20	92.0
k99_84883_3	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	37.9	649	631	703	3.58e-116	361
k99_84883_6	SARG|gb|AEO25219.1|ARO:3004651|lin	24.0	200	270	523	2.12e-09	56.6
k99_84883_13	CARD|gb|AEX49906.1|ARO:3003583|basS	30.5	456	450	477	4.65e-46	165
k99_84883_13	NCBI|WP_011461302.1|1|1|vanS-I|vanS-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-I|AMR|glycopeptide	26.2	202	450	392	4.58e-09	57.0
k99_84883_14	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	219	1.36e-44	147
k99_84883_14	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	219	1.92e-44	147
k99_84883_14	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	220	1.98e-44	147
k99_84883_14	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	220	3.95e-44	146
k99_84883_14	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.2	218	220	220	9.92e-42	140
k99_84883_14	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	35.4	223	220	231	5.19e-38	130
k99_84883_14	CARD|gb|AAD51348.1|ARO:3003066|smeR	36.5	219	220	229	9.79e-38	130
k99_84883_14	CARD|gb|ADM92605.1|ARO:3000553|adeR	33.3	225	220	247	7.89e-30	110
k99_85510_13	CARD|gb|AAG05661.1|ARO:3004107|Paer_soxR	63.1	141	155	156	7.08e-62	186
k99_85510_14	CARD|gb|AFK13828.1|ARO:3000823|ramA	47.0	100	108	124	8.82e-32	107
k99_86060_14	CARD|gb|AAK37618.1|ARO:3005008|TxR	41.1	321	593	318	6.78e-64	211
k99_86742_4	SARG|A1AFX9	99.3	273	274	273	4.34e-192	525
k99_86742_4	SARG|ZP_03064089	99.3	273	274	274	4.50e-192	525
k99_86742_4	SARG|CAS10898	98.9	273	274	273	1.24e-191	524
k99_86742_4	SARG|gi|486204699|ref|WP_001551672.1|	98.9	273	274	273	1.24e-191	524
k99_86742_4	SARG|gi|641685979|emb|CDN83808.1|	98.9	273	274	274	1.29e-191	524
k99_86742_4	SARG|A8A4L2	98.9	273	274	273	1.77e-191	524
k99_86742_4	SARG|B7NJS0	98.9	273	274	273	2.51e-191	523
k99_86742_4	SARG|B7LQD5	98.2	273	274	273	5.06e-191	523
k99_86742_4	SARG|YP_312012	98.9	273	274	273	7.19e-191	522
k99_86742_4	SARG|NP_289632	98.5	273	274	273	2.06e-190	521
k99_89510_10	SARG|DQ212986.1.gene8.p01	39.0	251	307	349	5.57e-50	168
k99_89510_10	SARG|gi|405945042|pdb|4FU0|A	39.0	251	307	357	6.76e-50	168
k99_89510_10	SARG|gi|752682279|ref|WP_041330231.1|	38.0	250	307	349	7.83e-50	167
k99_89510_10	SARG|gi|765411304|ref|WP_044689514.1|	39.0	251	307	349	1.10e-49	167
k99_89510_10	SARG|AAF71281	38.6	251	307	349	3.06e-49	166
k99_89510_10	SARG|gi|1028100561|ref|WP_063856696.1|	37.6	250	307	349	2.35e-48	164
k99_89510_10	SARG|gi|257803688|gb|EEV32510.1|	34.4	343	307	344	4.11e-48	163
k99_89510_10	SARG|gi|1028100552|ref|WP_063856687.1|	34.4	340	307	343	7.93e-48	162
k99_89510_10	SARG|gi|355380870|gb|EHG28002.1|	34.4	343	307	344	8.12e-48	162
k99_89510_10	SARG|gi|751652141|ref|WP_041119007.1|	34.4	340	307	343	1.11e-47	162
k99_89846_1	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	21.6	273	274	552	2.94e-10	59.3
k99_89846_1	SARG|AXF35727.1	28.6	182	274	497	3.90e-09	55.8
k99_89846_1	SARG|gb|WP_082039181.1|ARO:3007028|salD	27.7	177	274	544	4.07e-09	55.8
k99_89846_1	ResF|poxtA-Ef_1_WP094899500.1_1	33.8	151	274	538	1.30e-08	54.3
k99_89846_1	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	33.8	151	274	543	1.30e-08	54.3
k99_89846_1	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	33.8	151	274	543	1.30e-08	54.3
k99_89846_1	SARG|gb|WP_096809342.1|ARO:3007029|salE	24.2	244	274	543	1.75e-08	53.9
k99_89846_1	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	25.5	188	274	505	2.26e-08	53.5
k99_89846_1	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	24.9	189	274	504	4.04e-08	52.8
k99_89846_1	SARG|gb|AVI44920.1|ARO:3004470|poxtA	28.6	147	274	542	2.38e-07	50.4
k99_89945_1	SARG|ACB17400	99.3	410	411	410	1.38e-289	783
k99_89945_1	SARG|gi|672850784|gb|KFH94025.1|	99.5	410	411	410	3.94e-289	782
k99_89945_1	SARG|ZP_02775049	99.3	410	411	410	5.60e-289	782
k99_89945_1	SARG|YP_002411785	99.3	410	411	410	5.60e-289	782
k99_89945_1	SARG|NP_752857	99.3	410	411	420	8.17e-289	782
k99_89945_1	SARG|BAG76424	99.0	410	411	410	1.60e-288	781
k99_89945_1	SARG|gi|928824385|ref|WP_053884538.1|	99.0	410	411	410	1.60e-288	781
k99_89945_1	SARG|YP_668774	99.0	410	411	410	2.28e-288	780
k99_89945_1	SARG|gi|332104663|gb|EGJ08009.1|	99.3	410	411	420	2.34e-288	781
k99_89945_1	SARG|ZP_03050303	99.3	410	411	410	3.24e-288	780
k99_89945_14	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	34.2	219	354	255	9.19e-36	129
k99_89945_14	SARG|gb|ADZ12699.1|ARO:3005091|RanA	32.7	214	354	258	1.53e-32	121
k99_89945_14	SARG|gi|895865878|ref|WP_048974758.1|	35.1	225	354	646	1.90e-29	118
k99_89945_14	SARG|gi|639209604|ref|WP_024547784.1|	33.8	225	354	648	8.94e-26	107
k99_90842_1	SARG|gi|1016547979|ref|WP_063116960.1|	38.2	102	363	648	1.33e-09	58.5
k99_90842_1	SARG|gi|446110279|ref|WP_000188134.1|	38.2	102	363	648	1.33e-09	58.5
k99_90842_1	SARG|gi|1036100176|ref|WP_064669414.1|	37.9	103	363	648	1.77e-09	58.2
k99_90842_1	SARG|NP_286651	37.6	101	363	648	1.77e-09	58.2
k99_90842_1	SARG|gi|446110334|ref|WP_000188189.1|	37.6	101	363	648	2.35e-09	57.8
k99_90842_1	SARG|gi|486425021|ref|WP_001614493.1|	38.6	101	363	648	2.35e-09	57.8
k99_90842_1	SARG|gi|693106883|ref|WP_032260279.1|	37.6	101	363	648	3.13e-09	57.4
k99_90842_1	SARG|gi|723111645|ref|WP_033557217.1|	37.6	101	363	648	3.13e-09	57.4
k99_90842_1	SARG|gi|332091165|gb|EGI96255.1|	37.6	101	363	645	4.14e-09	57.0
k99_90842_1	SARG|gi|391288090|gb|EIQ46599.1|	37.6	101	363	645	4.14e-09	57.0
k99_91493_14	CARD|gb|AAA99503.1|ARO:3003250|bcrC	29.7	182	199	203	3.63e-17	75.1
k99_92181_4	SARG|YP_002414661	99.5	385	386	385	1.12e-264	718
k99_92181_4	SARG|ACB17952	99.2	385	386	385	4.55e-264	717
k99_92181_4	SARG|gi|447004721|ref|WP_001081977.1|	99.0	385	386	385	6.46e-264	716
k99_92181_4	SARG|gi|754615047|ref|WP_042004421.1|	98.7	385	386	385	9.18e-264	716
k99_92181_4	SARG|gi|585341406|ref|WP_024223032.1|	99.0	385	386	385	1.30e-263	716
k99_92181_4	SARG|gi|447004719|ref|WP_001081975.1|	99.0	385	386	385	1.30e-263	716
k99_92181_4	SARG|ACI76101	99.0	385	386	385	1.85e-263	715
k99_92181_4	SARG|gi|545297853|ref|WP_021578058.1|	98.7	385	386	385	1.85e-263	715
k99_92181_4	SARG|gi|553929620|ref|WP_023140654.1|	99.0	385	386	385	1.85e-263	715
k99_92181_4	SARG|ZP_03043001	99.0	385	386	385	1.85e-263	715
k99_92181_5	SARG|ACB18310	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|ZP_03032068	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|gi|693231347|ref|WP_032343975.1|	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|gi|727763004|ref|WP_033868126.1|	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|gi|693052542|ref|WP_032221381.1|	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|YP_002400010	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|gi|486192935|ref|WP_001544991.1|	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|YP_859120	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|gi|693063576|ref|WP_032229546.1|	100	188	188	1037	3.64e-116	352
k99_92181_5	SARG|gi|692982586|ref|WP_032172458.1|	100	188	188	1037	3.64e-116	352
k99_93109_2	CARD|gb|VWQ00850.1|ARO:3003843|leuO	99.4	314	315	314	4.87e-230	625
k99_95187_13	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	38.4	425	441	429	1.07e-86	270
k99_95187_15	CARD|gb|ALH22601.1|ARO:3000620|adeL	36.8	288	324	337	2.74e-60	195
k99_95661_3	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	36.3	201	223	255	1.10e-40	138
k99_95661_3	SARG|gi|694064328|ref|WP_032410816.1|	37.3	204	223	646	2.75e-37	136
k99_95661_3	SARG|gi|447195835|ref|WP_001273091.1|	29.6	216	223	306	2.31e-21	89.0
k99_95661_3	SARG|gi|507055561|ref|WP_016126482.1|	28.2	216	223	309	2.40e-21	89.0
k99_95661_3	SARG|gi|488053456|ref|WP_002124853.1|	28.2	216	223	309	3.32e-21	88.6
k99_95661_3	SARG|gi|488068784|ref|WP_002140181.1|	27.8	216	223	309	3.32e-21	88.6
k99_95661_3	SARG|gi|447057510|ref|WP_001134766.1|	27.8	216	223	309	3.32e-21	88.6
k99_95661_3	SARG|gi|500194536|ref|WP_011867743.1|	28.1	221	223	306	4.43e-21	88.2
k99_95661_3	SARG|gi|488067981|ref|WP_002139378.1|	27.8	216	223	309	4.60e-21	88.2
k99_95661_3	SARG|gi|487936534|ref|WP_002010000.1|	27.8	216	223	309	4.60e-21	88.2
k99_101258_1	CARD|gb|AAC75429.1|ARO:3000833|evgS	29.8	399	870	1197	2.25e-35	144
k99_101258_3	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	36.7	240	231	252	2.42e-44	148
k99_101258_3	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	32.3	229	231	239	1.67e-34	122
k99_101258_3	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	31.6	228	231	232	1.97e-34	122
k99_101258_3	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	31.6	225	231	232	3.91e-34	121
k99_101258_3	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	31.9	226	231	225	1.29e-33	119
k99_101258_3	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	30.9	230	231	231	8.96e-32	115
k99_101258_3	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	33.3	225	231	231	1.26e-31	114
k99_101258_3	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	30.4	230	231	231	2.49e-31	114
k99_101258_3	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	31.1	228	231	231	2.69e-30	111
k99_101258_3	CARD|gb|AAD51348.1|ARO:3003066|smeR	34.8	224	231	229	3.61e-30	110
k99_101631_4	SARG|gi|694064328|ref|WP_032410816.1|	31.5	216	257	646	2.02e-16	77.4
k99_102525_2	SARG|gi|542061059|gb|ERI11611.1|	37.1	221	912	316	6.00e-42	155
k99_102525_2	SARG|P42332	36.7	229	912	306	1.37e-40	150
k99_102525_2	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	36.7	229	912	306	1.37e-40	150
k99_102525_2	SARG|gi|510143239|gb|AGN36970.1|	36.7	229	912	313	1.63e-40	150
k99_102525_2	SARG|ABB80128	36.2	229	912	306	6.35e-40	149
k99_102525_2	SARG|AAD21213	36.2	229	912	306	8.63e-40	148
k99_102525_2	SARG|YP_001373621	36.0	211	912	318	5.35e-39	146
k99_102525_2	SARG|gi|447195835|ref|WP_001273091.1|	35.5	211	912	306	1.57e-37	142
k99_102525_2	SARG|gi|447057509|ref|WP_001134765.1|	37.1	213	912	309	1.69e-37	142
k99_102525_2	SARG|gi|447057510|ref|WP_001134766.1|	36.6	213	912	309	2.29e-37	141
k99_104685_2	SARG|gi|1004359922|gb|AMP42228.1|	26.8	436	600	639	7.73e-28	117
k99_104685_2	SARG|ABN80187	26.8	436	600	640	5.80e-27	114
k99_104685_2	SARG|gb|AMP42147.1|ARO:3004442|tet(W/N/W)	25.5	435	600	639	2.42e-26	112
k99_104685_2	SARG|AAO42740	25.8	434	600	639	7.61e-26	111
k99_104685_2	SARG|AY485126.gene.p01	25.8	434	600	639	7.61e-26	111
k99_104685_2	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.8	434	600	639	7.61e-26	111
k99_104685_2	SARG|gi|1028100280|ref|WP_063856415.1|	26.0	434	600	639	7.61e-26	111
k99_104685_2	SARG|ABN79417	26.9	438	600	639	1.01e-25	110
k99_104685_2	SARG|ACI02041	25.5	435	600	639	1.01e-25	110
k99_104685_2	SARG|gi|104303742|gb|ABF72138.1|	26.7	439	600	639	1.35e-25	110
k99_106030_1	SARG|YP_002414662	100	803	804	1037	0.0	1499
k99_106030_1	SARG|gi|445946986|ref|WP_000024841.1|	99.9	803	804	1037	0.0	1498
k99_106030_1	SARG|YP_002272991	99.8	803	804	1037	0.0	1497
k99_106030_1	SARG|gi|727763004|ref|WP_033868126.1|	99.9	803	804	1037	0.0	1497
k99_106030_1	SARG|gi|487583784|ref|WP_001724011.1|	99.8	803	804	1037	0.0	1496
k99_106030_1	SARG|gi|693118280|ref|WP_032268080.1|	99.8	803	804	1037	0.0	1496
k99_106030_1	SARG|gi|486233868|ref|WP_001560073.1|	99.8	803	804	1037	0.0	1496
k99_106030_1	SARG|YP_001460310	99.8	803	804	1037	0.0	1496
k99_106030_1	SARG|gi|485766147|ref|WP_001390776.1|	99.8	803	804	1037	0.0	1496
k99_106030_1	SARG|gi|487380919|ref|WP_001653479.1|	99.8	803	804	1037	0.0	1496
k99_106030_2	CARD|gb|ANK04027.1|ARO:3003838|gadW	95.9	242	243	242	2.31e-167	460
k99_106783_6	ResF|penA_1_AF515059_1	36.3	485	490	581	1.66e-105	325
k99_106783_6	NCBI|WP_063852700.1|1|1|mecA2|mecA2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecA2|AMR|beta-lactam	23.5	446	490	668	8.32e-22	97.8
k99_106783_6	megares|MEG_3790|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.6	446	490	666	1.47e-21	97.1
k99_106783_6	megares|MEG_3789|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.7	427	490	668	1.97e-21	96.7
k99_106783_6	megares|MEG_3793|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.7	427	490	668	3.49e-21	95.9
k99_106783_6	SARG|gi|686322767|ref|WP_031876626.1|	22.7	427	490	668	3.49e-21	95.9
k99_106783_6	SARG|CAA70425	22.8	426	490	666	6.17e-21	95.1
k99_106783_6	SARG|gi|686195077|ref|WP_031806544.1|	22.7	427	490	668	6.19e-21	95.1
k99_106783_6	SARG|gi|686132960|ref|WP_031774065.1|	22.5	427	490	668	6.19e-21	95.1
k99_106783_6	NCBI|WP_063852694.1|1|1|mecA2|mecA2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecA2|AMR|beta-lactam	23.3	446	490	668	6.19e-21	95.1
k99_106954_10	CARD|gb|AAD51347.1|ARO:3003067|smeS	25.4	311	919	467	1.66e-19	91.7
k99_106954_10	CARD|gb|AAC75429.1|ARO:3000833|evgS	26.3	255	919	1197	2.76e-13	73.2
k99_106954_10	CARD|gb|ATC67679.1|ARO:3000838|arlR	28.2	142	919	219	1.44e-09	58.2
k99_106954_10	CARD|gb|AAD51348.1|ARO:3003066|smeR	29.4	126	919	229	7.89e-08	53.1
k99_106954_10	CARD|gb|AAG06465.1|ARO:3005063|cprR	30.4	161	919	223	3.23e-07	51.2
k99_106954_10	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	32.0	103	919	225	1.45e-06	49.3
k99_106954_10	CARD|gb|AAC73788.1|ARO:3003841|kdpE	32.0	103	919	225	1.45e-06	49.3
k99_107578_9	SARG|gi|299882142|gb|EFI90353.1|	26.5	219	418	443	2.71e-11	63.9
k99_107578_9	SARG|gi|391256340|gb|EIQ15472.1|	26.9	212	418	410	3.30e-11	63.5
k99_107578_9	SARG|gi|693117414|ref|WP_032267527.1|	27.4	212	418	410	7.77e-11	62.4
k99_107578_9	SARG|AF034958.gene.p01	27.1	229	418	409	1.03e-10	62.0
k99_107578_9	megares|MEG_1774|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLB_1	27.1	229	418	409	1.03e-10	62.0
k99_107578_9	SARG|gi|447059751|ref|WP_001137007.1|	26.9	212	418	410	1.03e-10	62.0
k99_107578_9	SARG|gi|490068104|ref|WP_003970282.1|	26.9	212	418	410	1.03e-10	62.0
k99_107578_9	SARG|ZP_03044758	26.9	212	418	410	1.03e-10	62.0
k99_107578_9	SARG|YP_001882916	26.9	212	418	410	1.03e-10	62.0
k99_107578_9	SARG|gi|487412532|ref|WP_001680159.1|	26.9	212	418	410	1.03e-10	62.0
k99_107578_12	CARD|gb|BAH63252.1|ARO:3004583|Kpne_KpnF	84.4	109	110	109	3.87e-65	191
k99_107578_12	SARG|gb|AEH26330.1|ARO:3005009|qacE	36.7	98	110	110	1.76e-16	68.2
k99_107578_13	CARD|gb|BAH63251.1|ARO:3004580|Kpne_KpnE	82.2	118	122	120	6.47e-58	174
k99_107578_13	SARG|gb|AEH26330.1|ARO:3005009|qacE	30.6	98	122	110	1.74e-10	53.1
k99_107578_13	SARG|gb|AAC44316.1|ARO:3005010|qacEdelta1	29.4	109	122	115	5.37e-10	52.0
k99_107578_13	SARG|gb|AAZ42322.1|ARO:3003836|qacH	28.7	101	122	110	4.00e-08	47.0
k99_107578_14	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	21.5	317	345	397	1.49e-07	51.6
k99_108862_12	SARG|gi|912614197|ref|WP_050196089.1|	35.7	221	372	648	2.25e-28	115
k99_108862_12	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.5	220	372	343	2.89e-23	98.2
k99_108862_12	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	28.8	219	372	307	6.09e-23	96.7
k99_108862_12	SARG|gi|953808775|ref|WP_058042812.1|	33.3	222	372	608	3.78e-21	94.0
k99_108862_12	SARG|gb|AAK76137.1|ARO:3000024|patA	27.5	233	372	564	2.43e-16	79.3
k99_108862_12	SARG|gb|NP_388442.1|ARO:3004476|vmlR	29.3	208	372	547	2.45e-13	70.1
k99_108862_12	NCBI|WP_011116970.1|1|1|tetAB_B|tetAB_B|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_TetAB_subunit_B|AMR|tetracycline	28.2	209	372	528	3.83e-08	53.9
k99_109447_5	SARG|gb|APB03222.1|ARO:3003992|rphB	35.6	331	793	884	9.26e-46	175
k99_109447_5	NCBI|WP_087347987.1|1|1|rphC|rphC||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphC|AMR|rifamycin	34.8	333	793	868	2.81e-44	171
k99_109447_5	SARG|gb|AIA08936.1|ARO:3000444|rphA	37.0	327	793	865	1.58e-43	168
k99_109447_5	NCBI|WP_087348261.1|1|1|rphD|rphD||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphD|AMR|rifamycin	34.5	333	793	872	1.62e-43	168
k99_109889_6	megares|MEG_2614|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|DHAP_1	26.4	246	411	395	1.15e-16	80.1
k99_114645_1	CARD|gb|BAE77933.1|ARO:3000518|CRP	99.5	190	190	210	1.02e-135	377
k99_114645_6	SARG|GQ205627.2.gene1.p01	31.8	192	320	525	1.49e-23	99.8
k99_114645_6	SARG|gb|QHW12375.1|ARO:3005087|msrF	30.4	184	320	486	9.14e-22	94.4
k99_114645_6	SARG|QHW12308.1	30.8	185	320	486	1.24e-21	94.0
k99_114645_6	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	33.0	179	320	461	9.38e-21	91.3
k99_114645_6	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	32.4	179	320	461	1.27e-20	90.9
k99_114645_6	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	32.0	194	320	568	2.29e-20	90.5
k99_114645_6	NCBI|WP_000052512.1|1|1|msr(E)|msr(E)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(E)|AMR|multidrug	34.8	198	320	491	8.69e-20	88.6
k99_114645_6	SARG|X63451.gene.p01	33.5	188	320	550	1.34e-19	88.2
k99_114645_6	megares|MEG_6558|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SRMB_1	33.5	188	320	550	1.34e-19	88.2
k99_114645_6	NCBI|AFC62715.1|1|1|eat(A)|eat(A)|target_protection|0|PLEUROMUTILIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Eat(A)|AMR|pleuromutilin	28.4	201	320	500	3.75e-16	77.8
k99_114692_1	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	100	412	412	633	2.73e-300	820
k99_114692_1	SARG|gi|2791908|emb|CAA73538.1|	29.7	364	412	666	4.32e-38	144
k99_114692_1	megares|MEG_3792|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	29.7	364	412	666	5.89e-38	144
k99_114692_1	NCBI|WP_128268231.1|1|1|mecC2|mecC2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecC2|AMR|beta-lactam	28.3	368	412	665	5.11e-37	141
k99_114692_1	megares|MEG_3799|Drugs|beta-lactam|Penicillin_binding_protein|MECC_1	29.5	363	412	664	1.75e-36	140
k99_114692_1	NCBI|WP_069996660.1|1|1|mecC3|mecC3|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecC3|AMR|beta-lactam	29.5	363	412	665	3.25e-36	139
k99_114692_1	SARG|gb|CCC86795.1|ARO:3001209|mecC	29.4	364	412	665	6.01e-36	138
k99_114692_1	megares|MEG_3800|Drugs|beta-lactam|Penicillin_binding_protein|MECC_1	28.9	363	412	665	1.75e-34	134
k99_114692_8	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	22.3	986	861	1107	9.21e-15	77.8
k99_114692_8	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	22.3	986	861	1107	9.21e-15	77.8
k99_116541_10	SARG|gi|496018010|ref|WP_008742581.1|	42.0	69	74	623	7.33e-10	52.0
k99_116541_10	SARG|gi|860594225|ref|WP_048475168.1|	51.1	45	74	620	1.37e-09	51.2
k99_116541_10	SARG|gi|926400371|ref|WP_053728483.1|	48.9	45	74	603	8.97e-09	48.9
k99_117025_10	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	100	92	93	225	3.86e-64	192
k99_117025_10	CARD|gb|AAC73788.1|ARO:3003841|kdpE	100	92	93	225	3.86e-64	192
k99_117025_10	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	33.3	75	93	231	2.82e-13	61.6
k99_117025_10	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	30.7	75	93	230	1.46e-12	59.7
k99_117025_10	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	33.8	74	93	231	2.84e-12	58.9
k99_117911_7	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	47.8	228	233	225	3.18e-64	198
k99_117911_7	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	230	233	231	5.74e-50	162
k99_117911_7	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	39.8	226	233	232	5.90e-50	162
k99_117911_7	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	38.0	229	233	230	1.57e-49	160
k99_117911_7	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	38.8	224	233	231	1.62e-49	160
k99_117911_7	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.7	228	233	232	4.71e-49	159
k99_117911_7	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.7	228	233	232	4.71e-49	159
k99_117911_7	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	38.6	236	233	252	6.59e-48	157
k99_117911_7	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	37.4	230	233	231	1.03e-47	156
k99_117911_7	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	36.5	230	233	231	8.19e-47	154
k99_117911_8	CARD|gb|BAB38260.1|ARO:3000830|cpxA	100	326	326	457	4.03e-225	619
k99_118887_5	SARG|Q83LR7	37.8	185	256	648	8.63e-30	116
k99_118887_5	SARG|gi|647325472|ref|WP_025760953.1|	37.8	185	256	648	8.63e-30	116
k99_118887_5	SARG|gi|647323678|ref|WP_025760497.1|	37.8	185	256	648	8.63e-30	116
k99_118887_5	SARG|gi|696368937|ref|WP_032943949.1|	33.7	205	256	648	2.97e-29	114
k99_118887_5	SARG|gi|851913025|ref|WP_048215946.1|	33.7	205	256	648	2.97e-29	114
k99_118887_5	SARG|gi|446110305|ref|WP_000188160.1|	37.3	185	256	648	2.97e-29	114
k99_118887_5	SARG|gi|489930965|ref|WP_003834285.1|	33.7	205	256	648	2.97e-29	114
k99_118887_5	SARG|gi|654658955|ref|WP_028119847.1|	36.8	185	256	648	4.04e-29	114
k99_118887_5	SARG|gi|696361545|ref|WP_032936694.1|	33.7	205	256	648	4.04e-29	114
k99_118887_5	SARG|gi|489936909|ref|WP_003840216.1|	33.7	205	256	648	4.04e-29	114
k99_118887_11	megares|MEG_729|Drugs|beta-lactam|Penicillin_binding_protein|AMPH_1	99.2	376	377	385	1.67e-275	745
k99_118887_11	megares|MEG_730|Drugs|beta-lactam|Penicillin_binding_protein|AMPH_1	86.1	375	377	386	2.15e-237	649
k99_118887_11	SARG|gb|WP_109791215.1|ARO:3005183|CMY-160	23.6	368	377	381	1.61e-18	85.1
k99_118887_11	SARG|gb|AFU25638.1|ARO:3002096|CMY-83	22.8	368	377	381	1.61e-18	85.1
k99_118887_11	SARG|AAM11668	23.4	368	377	381	1.61e-18	85.1
k99_118887_11	NCBI|WP_430673476.1|1|1|blaCMY-219|blaCMY|hydrolase|2|CEPHALOSPORIN|beta-lactam|class_C_beta-lactamase_CMY-219|AMR|beta-lactam	23.6	368	377	381	2.18e-18	84.7
k99_118887_11	NCBI|WP_394294891.1|1|1|blaCMY-197|blaCMY|hydrolase|2|CEPHALOSPORIN|beta-lactam|class_C_beta-lactamase_CMY-197|AMR|beta-lactam	23.6	368	377	381	2.18e-18	84.7
k99_118887_11	SARG|gb|WP_063859788.1|ARO:3003170|CMY-131	23.6	368	377	381	2.94e-18	84.3
k99_118887_11	SARG|gb|WP_075985684.1|ARO:3005197|CMY-145	23.6	368	377	381	3.97e-18	84.0
k99_118887_11	SARG|gb|WP_094009802.1|ARO:3005200|CMY-155	23.1	368	377	381	3.97e-18	84.0
k99_121455_3	CARD|gb|AAK37618.1|ARO:3005008|TxR	40.4	265	470	318	5.16e-57	190
k99_121455_3	SARG|ZP_02848503	33.0	103	470	221	3.47e-10	58.9
k99_121455_3	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	219	1.51e-09	57.0
k99_121455_3	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	219	1.51e-09	57.0
k99_121455_3	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	220	1.53e-09	57.0
k99_121455_3	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	220	2.07e-09	56.6
k99_121455_3	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.7	101	470	220	7.43e-08	52.0
k99_123617_7	SARG|gi|896514456|ref|WP_049420414.1|	28.4	116	454	387	1.47e-09	58.5
k99_123617_7	SARG|gi|881042407|ref|WP_048761349.1|	28.4	116	454	387	1.47e-09	58.5
k99_123617_7	SARG|gi|518673227|ref|WP_019834920.1|	28.4	116	454	387	1.47e-09	58.5
k99_123617_7	SARG|gi|896507999|ref|WP_049415454.1|	28.4	116	454	387	1.47e-09	58.5
k99_123617_7	SARG|gi|896534839|ref|WP_049437516.1|	28.4	116	454	387	3.45e-09	57.4
k99_123617_7	SARG|gi|739700146|ref|WP_037554487.1|	28.4	116	454	387	3.45e-09	57.4
k99_123617_7	SARG|ZP_04060517	28.4	116	454	387	3.45e-09	57.4
k99_123617_7	SARG|gi|896396316|ref|WP_049335029.1|	28.4	116	454	387	3.45e-09	57.4
k99_123617_7	SARG|gi|313655620|gb|EFS19365.1|	28.4	116	454	390	3.49e-09	57.4
k99_123617_7	SARG|ZP_03592168	29.4	119	454	389	6.13e-09	56.6
k99_126006_5	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	29.9	308	309	343	1.95e-39	140
k99_126006_5	SARG|gi|542061059|gb|ERI11611.1|	31.2	311	309	316	1.26e-36	132
k99_126006_5	SARG|gi|447057509|ref|WP_001134765.1|	32.7	306	309	309	5.77e-36	130
k99_126006_5	SARG|YP_001373621	32.7	306	309	318	1.91e-35	129
k99_126006_5	SARG|gi|445996708|ref|WP_000074563.1|	31.8	311	309	309	2.20e-35	129
k99_126006_5	SARG|ZP_04081918	32.1	315	309	306	2.89e-35	128
k99_126006_5	SARG|gi|488130770|ref|WP_002201978.1|	33.0	306	309	309	3.08e-35	128
k99_126006_5	SARG|gi|507035724|ref|WP_016107411.1|	32.0	306	309	309	4.31e-35	128
k99_126006_5	SARG|gi|445996697|ref|WP_000074552.1|	32.0	306	309	309	6.02e-35	127
k99_126006_5	SARG|gi|447195835|ref|WP_001273091.1|	30.2	318	309	306	7.89e-35	127
k99_126006_7	SARG|BAB59035	32.1	137	179	154	2.69e-07	47.0
k99_126006_7	SARG|Q8DF90	33.9	115	179	154	3.71e-07	46.6
k99_126006_7	SARG|YP_002418004	31.4	137	179	154	5.12e-07	46.2
k99_126006_7	SARG|ZP_01813310	31.4	137	179	154	7.05e-07	45.8
k99_126006_7	SARG|ZP_00990220	31.4	137	179	154	7.05e-07	45.8
k99_126006_7	SARG|BAC58936	33.0	115	179	154	9.70e-07	45.4
k99_126006_7	SARG|YP_001444376	29.9	137	179	154	4.77e-06	43.5
k99_126006_7	SARG|YP_002666586	29.9	137	179	154	4.77e-06	43.5
k99_126006_7	SARG|ZP_02197344	31.3	115	179	154	6.55e-06	43.1
k99_126183_6	CARD|gb|CAA79966.1|ARO:3003665|NmcR	33.7	291	306	295	7.63e-46	155
k99_126183_6	megares|MEG_1992|Drugs|beta-lactam|Class_C_betalactamases|CMY_1	32.2	289	306	291	8.78e-43	147
k99_131213_13	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	59.6	399	396	374	1.48e-157	447
k99_131213_13	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	54.6	388	396	357	2.34e-112	332
k99_134396_3	NCBI|WP_011906899.1|1|1|estDL136|estDL136||2|CHLORAMPHENICOL/FLORFENICOL|PHENICOL|phenicol_hydrolase|AMR|phenicol	30.3	228	320	308	4.42e-28	109
k99_134396_3	megares|MEG_2865|Drugs|Phenicol|Chloramphenicol_hydrolase|ESTD_1	30.1	249	320	310	3.26e-27	107
k99_134964_2	SARG|CP001581.1.gene725.p01	32.9	383	432	477	4.89e-57	194
k99_134964_2	SARG|NP_733568	31.8	396	432	536	4.87e-41	152
k99_134964_2	SARG|YP_002196817	29.5	410	432	536	1.02e-37	142
k99_134964_2	SARG|NC_002951.3237948.p01	27.4	401	432	643	7.86e-36	138
k99_134964_2	SARG|BAA07390	32.4	404	432	512	8.99e-36	137
k99_134964_2	SARG|AAC15775	30.3	406	432	536	9.85e-32	125
k99_134964_2	SARG|AAD04032	30.3	406	432	563	1.21e-31	125
k99_134964_2	megares|MEG_4380|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	30.3	406	432	563	1.21e-31	125
k99_134964_2	megares|MEG_4381|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	30.3	406	432	563	1.21e-31	125
k99_134964_2	SARG|gb|BAB43261.1|ARO:3007013|sdrM	27.4	423	432	447	1.34e-28	115
k99_137742_4	SARG|FR772051.1.gene9.p01	24.7	194	272	524	1.26e-08	54.3
k99_137742_4	SARG|gb|AHB37625.1|ARO:3004715|vga(E)	23.7	219	272	524	1.68e-08	53.9
k99_137742_4	SARG|gi|686386599|ref|WP_031903183.1|	23.4	188	272	488	1.25e-07	51.2
k99_137742_4	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	24.4	201	272	568	1.77e-07	50.8
k99_137742_4	SARG|gi|686444151|ref|WP_031925491.1|	23.9	188	272	488	2.23e-07	50.4
k99_137742_4	SARG|gi|581672381|gb|EVQ77821.1|	23.4	188	272	394	2.66e-07	50.1
k99_137742_4	SARG|gi|587321226|gb|EWW03298.1|	23.4	188	272	413	2.74e-07	50.1
k99_137742_4	SARG|gi|580336413|gb|EVD62957.1|	23.4	188	272	478	2.95e-07	50.1
k99_137742_4	SARG|YP_001569068	23.4	188	272	488	2.98e-07	50.1
k99_137742_4	SARG|gi|686379454|ref|WP_031899389.1|	23.4	188	272	488	2.98e-07	50.1
k99_137852_4	CARD|gb|BAB36671.1|ARO:3000832|evgA	27.2	206	219	204	1.01e-20	85.1
k99_137852_4	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	29.3	116	219	228	2.84e-07	48.5
k99_137852_6	CARD|gb|AAL20862.1|ARO:3000826|sdiA	72.1	240	241	240	1.28e-124	352
k99_138029_6	SARG|gi|445996732|ref|WP_000074587.1|	27.3	245	269	309	2.29e-19	84.7
k99_138029_6	SARG|gi|507035724|ref|WP_016107411.1|	26.2	244	269	309	3.15e-19	84.3
k99_138029_6	SARG|gi|445996708|ref|WP_000074563.1|	27.7	238	269	309	5.96e-19	83.6
k99_138029_6	SARG|gi|500194536|ref|WP_011867743.1|	26.1	241	269	306	7.91e-19	83.2
k99_138029_6	SARG|gi|445996698|ref|WP_000074553.1|	25.8	244	269	309	8.19e-19	83.2
k99_138029_6	SARG|gi|445996697|ref|WP_000074552.1|	26.2	244	269	309	8.19e-19	83.2
k99_138029_6	SARG|gi|445996696|ref|WP_000074551.1|	26.2	244	269	309	1.13e-18	82.8
k99_138029_6	SARG|gi|445996719|ref|WP_000074574.1|	26.9	238	269	309	1.55e-18	82.4
k99_138029_6	SARG|gi|447057509|ref|WP_001134765.1|	26.3	255	269	309	1.55e-18	82.4
k99_138029_6	SARG|gi|445996710|ref|WP_000074565.1|	26.9	238	269	309	1.55e-18	82.4
k99_138029_7	SARG|gi|922019548|ref|WP_053299973.1|	29.7	246	331	648	4.37e-19	87.0
k99_138029_7	SARG|gi|555268367|ref|WP_023249730.1|	29.3	246	331	648	1.06e-18	85.9
k99_138029_7	SARG|gi|1027935297|ref|WP_063809363.1|	29.3	246	331	648	1.06e-18	85.9
k99_138029_7	SARG|gi|555222481|ref|WP_023215070.1|	29.3	246	331	648	1.06e-18	85.9
k99_138029_7	SARG|gi|959866458|ref|WP_058145168.1|	29.8	245	331	648	1.43e-18	85.5
k99_138029_7	SARG|gi|555246906|ref|WP_023230855.1|	29.3	246	331	648	1.92e-18	85.1
k99_138029_7	SARG|YP_002044935	29.3	246	331	648	1.92e-18	85.1
k99_138029_7	SARG|gi|835666879|ref|WP_047606339.1|	29.3	246	331	648	1.92e-18	85.1
k99_138029_7	SARG|gi|685236936|ref|WP_031605176.1|	29.3	246	331	648	1.92e-18	85.1
k99_138029_7	SARG|gi|554958661|ref|WP_023203683.1|	29.3	246	331	648	1.92e-18	85.1
k99_139268_2	SARG|gi|896325272|ref|WP_049294291.1|	44.7	219	241	648	6.05e-46	160
k99_139268_2	SARG|gi|639216333|ref|WP_024554080.1|	44.5	209	241	648	8.07e-45	157
k99_139268_2	SARG|gi|639225329|ref|WP_024561799.1|	45.0	209	241	648	1.12e-44	157
k99_139268_2	SARG|gi|639218559|ref|WP_024556062.1|	45.0	209	241	648	1.12e-44	157
k99_139268_2	SARG|gi|657888313|ref|WP_029592374.1|	44.5	209	241	648	2.94e-44	156
k99_139268_2	SARG|gi|516510995|ref|WP_017899433.1|	39.7	237	241	646	2.76e-43	153
k99_139268_2	SARG|gi|490306253|ref|WP_004201358.1|	39.7	237	241	646	5.26e-43	152
k99_139268_2	SARG|gi|950164608|ref|WP_057214157.1|	39.7	237	241	646	5.26e-43	152
k99_139268_2	SARG|gi|896073592|ref|WP_049116987.1|	39.7	237	241	646	5.26e-43	152
k99_139268_2	SARG|gi|556468297|ref|WP_023320056.1|	39.7	237	241	646	5.26e-43	152
k99_139268_13	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.3	532	532	655	9.92e-82	266
k99_139268_13	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.3	532	532	655	9.92e-82	266
k99_139268_13	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	532	655	3.80e-81	265
k99_139268_13	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	532	655	5.32e-81	265
k99_139268_13	SARG|gb|AKA86814|ARO:3003746|optrA	32.1	532	532	655	5.32e-81	265
k99_139268_13	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	532	655	1.45e-80	263
k99_139268_13	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	532	655	1.45e-80	263
k99_139268_13	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	532	655	1.45e-80	263
k99_139268_13	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	532	655	1.45e-80	263
k99_139268_13	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	532	532	655	5.56e-80	262
k99_140985_5	SARG|gi|486340426|ref|WP_001587343.1|	100	512	513	512	0.0	999
k99_140985_5	SARG|NC_002695.1.914736.p01	99.8	512	513	512	0.0	996
k99_140985_5	SARG|gi|510905729|ref|WP_016232280.1|	99.6	512	513	512	0.0	995
k99_140985_5	SARG|gi|485736306|ref|WP_001363537.1|	99.6	512	513	512	0.0	995
k99_140985_5	SARG|gi|486183889|ref|WP_001539415.1|	99.6	512	513	512	0.0	995
k99_140985_5	SARG|gi|852042452|ref|WP_048266923.1|	99.6	512	513	512	0.0	995
k99_140985_5	SARG|gi|983457963|ref|WP_060617983.1|	99.6	512	513	512	0.0	994
k99_140985_5	SARG|gi|486215852|ref|WP_001556823.1|	99.4	512	513	512	0.0	994
k99_140985_5	SARG|gi|754733839|ref|WP_042102192.1|	99.6	512	513	512	0.0	994
k99_140985_5	SARG|gi|485862236|ref|WP_001461404.1|	99.6	512	513	512	0.0	994
k99_140985_6	SARG|gi|26109487|gb|AAN81690.1|AE016765_92	100	390	391	394	3.70e-262	712
k99_140985_6	SARG|gb|BAA16547.1|ARO:3000027|emrA	99.7	390	391	390	4.52e-262	712
k99_140985_6	SARG|gi|692990270|ref|WP_032178668.1|	99.7	390	391	390	4.52e-262	712
k99_140985_6	SARG|gi|765410328|ref|WP_044688844.1|	99.7	390	391	390	4.52e-262	712
k99_140985_6	SARG|gi|723107988|ref|WP_033555625.1|	99.7	390	391	390	4.52e-262	712
k99_140985_6	SARG|gi|545159469|ref|WP_021514432.1|	99.2	390	391	390	4.52e-262	712
k99_140985_6	SARG|gi|754634482|ref|WP_042021032.1|	99.7	390	391	390	4.52e-262	712
k99_140985_6	SARG|gi|545231023|ref|WP_021530660.1|	99.7	390	391	390	4.52e-262	712
k99_140985_6	SARG|gi|510905726|ref|WP_016232279.1|	99.5	390	391	390	6.42e-262	712
k99_140985_6	SARG|gi|693139934|ref|WP_032281480.1|	99.7	390	391	390	9.12e-262	711
k99_140985_7	CARD|gb|AAC75731.1|ARO:3000516|emrR	99.4	176	177	176	2.00e-124	346
k99_140985_10	SARG|gb|AEV23046.1|ARO:3007019|fexB	22.9	188	395	469	1.58e-06	48.9
k99_140985_13	SARG|gi|921979807|ref|WP_053271336.1|	34.2	202	401	648	2.52e-29	119
k99_140985_13	SARG|gi|542061059|gb|ERI11611.1|	29.4	235	401	316	3.20e-29	114
k99_140985_13	SARG|gi|500194536|ref|WP_011867743.1|	30.9	207	401	306	2.41e-27	109
k99_140985_13	SARG|gi|447057509|ref|WP_001134765.1|	30.4	207	401	309	1.74e-26	107
k99_140985_13	SARG|gi|507035724|ref|WP_016107411.1|	30.0	207	401	309	2.39e-26	106
k99_140985_13	SARG|gi|488042066|ref|WP_002113463.1|	30.0	207	401	309	2.39e-26	106
k99_140985_13	SARG|gi|445996696|ref|WP_000074551.1|	30.0	207	401	309	2.39e-26	106
k99_140985_13	SARG|gi|445996697|ref|WP_000074552.1|	30.0	207	401	309	3.29e-26	106
k99_140985_13	SARG|gi|488068784|ref|WP_002140181.1|	30.4	207	401	309	3.29e-26	106
k99_140985_13	SARG|gi|488120365|ref|WP_002191762.1|	30.7	202	401	309	4.53e-26	105
k99_140985_23	CARD|gb|BAB35162.1|ARO:3000676|H-NS	60.0	135	135	137	1.97e-40	130
k99_141028_2	SARG|gb|AAV85982.1|ARO:3000535|macB	35.6	205	233	644	8.63e-28	109
k99_141028_2	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.8	216	233	664	3.64e-17	79.0
k99_141028_2	SARG|gb|CDO61516.1|ARO:3003949|efrB	34.0	156	233	362	1.18e-15	73.9
k99_141028_2	SARG|gb|AAK76136.1|ARO:3000025|patB	26.8	213	233	588	1.48e-14	71.2
k99_141853_3	SARG|gb|AAC74000.1|ARO:3003950|msbA	28.7	519	574	582	2.53e-49	179
k99_141853_3	SARG|gi|928900436|ref|WP_053931243.1|	27.1	520	574	600	1.62e-48	177
k99_141853_3	SARG|gi|664579989|ref|WP_031094015.1|	27.1	520	574	601	1.64e-48	177
k99_141853_3	SARG|gi|695887424|ref|WP_032788534.1|	27.0	562	574	605	6.18e-48	175
k99_141853_3	SARG|gi|764446018|ref|WP_044369325.1|	26.4	561	574	605	1.16e-47	174
k99_141853_3	SARG|gi|664180077|ref|WP_030714054.1|	26.4	561	574	605	1.16e-47	174
k99_141853_3	SARG|gi|926294973|ref|WP_053631154.1|	27.7	564	574	620	1.42e-47	174
k99_141853_3	SARG|gi|926356413|ref|WP_053687351.1|	27.7	564	574	620	1.95e-47	174
k99_141853_3	SARG|gi|1045390184|ref|WP_065479071.1|	26.7	501	574	605	2.19e-47	174
k99_141853_3	SARG|gi|827013130|ref|WP_047175495.1|	27.5	501	574	603	2.93e-47	173
k99_141853_4	SARG|gb|AAC74000.1|ARO:3003950|msbA	26.9	432	589	582	1.28e-40	154
k99_141853_4	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	22.4	549	589	574	1.62e-33	134
k99_141853_4	SARG|gi|1033309939|gb|OAS18676.1|	23.3	210	589	492	2.52e-07	52.4
k99_141853_4	SARG|gi|1043542993|ref|WP_065386235.1|	23.8	210	589	492	5.34e-06	48.1
k99_141853_4	SARG|gi|490350160|ref|WP_004229933.1|	21.6	231	589	493	5.35e-06	48.1
k99_141853_4	SARG|gi|926250866|ref|WP_053589133.1|	21.0	248	589	492	9.30e-06	47.4
k99_149859_1	SARG|NP_348076	37.8	278	290	652	4.36e-47	166
k99_149859_1	SARG|YP_002850805	35.9	276	290	652	8.33e-47	165
k99_149859_1	SARG|L42544.gene.p01	36.8	277	290	651	3.01e-46	163
k99_149859_1	SARG|AAV80410	36.8	277	290	651	3.01e-46	163
k99_149859_1	SARG|ZP_02952732	35.5	276	290	652	8.01e-46	162
k99_149859_1	SARG|L20800.gene.p01	35.5	276	290	652	8.01e-46	162
k99_149859_1	SARG|ZP_02632674	35.5	276	290	660	8.62e-46	162
k99_149859_1	megares|MEG_7163|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	34.7	271	290	629	7.40e-42	151
k99_149859_1	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	34.7	271	290	629	7.40e-42	151
k99_149859_1	ResF|tet(O/W)_3_AM889120_1	34.7	271	290	639	8.03e-42	151
k99_149859_14	SARG|YP_001401994	31.3	444	479	563	1.08e-49	177
k99_149859_14	SARG|AAS61092	31.3	444	479	563	1.08e-49	177
k99_149859_14	SARG|ZP_04615639	31.8	446	479	543	1.09e-49	177
k99_149859_14	SARG|gi|740410309|ref|WP_038243756.1|	31.8	446	479	563	1.50e-49	177
k99_149859_14	SARG|ZP_04631861	32.3	446	479	543	2.88e-49	176
k99_149859_14	SARG|YP_001605795	30.9	443	479	562	5.40e-49	175
k99_149859_14	SARG|ZP_04612557	32.3	446	479	543	1.06e-48	174
k99_149859_14	SARG|ZP_04635128	31.8	446	479	543	2.03e-48	173
k99_149859_14	SARG|ZP_04630103	31.8	446	479	543	2.81e-48	173
k99_149859_14	SARG|ZP_04638974	31.8	446	479	563	5.29e-48	172
k99_149859_16	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	3.19e-54	187
k99_149859_16	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	4.43e-54	187
k99_149859_16	SARG|gb|AKA86814|ARO:3003746|optrA	33.2	352	350	655	4.43e-54	187
k99_149859_16	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	6.14e-54	186
k99_149859_16	megares|MEG_4311|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	8.52e-54	186
k99_149859_16	megares|MEG_4305|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	8.52e-54	186
k99_149859_16	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	1.18e-53	186
k99_149859_16	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	1.18e-53	186
k99_149859_16	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	1.18e-53	186
k99_149859_16	megares|MEG_4317|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.2	352	350	655	1.18e-53	186
k99_151530_1	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	32.1	224	411	323	1.54e-24	102
k99_151530_1	SARG|gi|746609237|ref|WP_039635344.1|	29.6	257	411	322	2.85e-24	101
k99_151530_1	SARG|gi|740152780|ref|WP_037997109.1|	30.1	226	411	322	4.78e-23	97.8
k99_151530_1	SARG|DQ018711.1.gene4.p01	29.2	257	411	322	6.53e-23	97.4
k99_151530_1	SARG|gi|738848198|ref|WP_036737307.1|	31.3	262	411	323	1.69e-22	96.3
k99_151530_1	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	31.7	227	411	351	8.43e-22	94.7
k99_151530_1	SARG|gi|737310392|ref|WP_035293250.1|	28.8	257	411	323	1.09e-21	94.0
k99_151530_1	SARG|AF155139.2.gene6.p01	28.6	255	411	322	1.46e-21	93.6
k99_151530_1	SARG|gi|749574782|ref|WP_040203616.1|	32.2	233	411	323	3.75e-21	92.4
k99_151530_1	SARG|FJ349556.1.gene5.p01	29.6	247	411	326	3.90e-21	92.4
k99_152016_6	SARG|gi|976150171|ref|WP_059308384.1|	38.9	229	258	646	2.09e-40	146
k99_152016_6	SARG|gi|992390012|ref|WP_061077002.1|	41.4	215	258	648	5.51e-40	145
k99_152016_6	SARG|gi|968563772|ref|WP_058587854.1|	41.3	213	258	648	1.04e-39	144
k99_152016_6	SARG|gi|757782629|ref|WP_043001213.1|	41.3	213	258	648	1.04e-39	144
k99_152016_6	SARG|gi|763407609|ref|WP_044264203.1|	41.3	213	258	648	1.04e-39	144
k99_152016_6	SARG|gi|817104523|ref|WP_046477871.1|	41.3	213	258	648	1.97e-39	143
k99_152016_6	SARG|gi|764278838|ref|WP_044327089.1|	41.3	213	258	648	1.97e-39	143
k99_152016_6	SARG|gi|754964360|ref|WP_042320280.1|	41.3	213	258	648	2.71e-39	143
k99_152016_6	SARG|gi|749017716|ref|WP_040076354.1|	38.6	215	258	646	5.05e-39	142
k99_152016_6	SARG|gi|754927849|ref|WP_042284850.1|	41.5	212	258	648	5.11e-39	142
k99_152307_3	SARG|gi|554685678|ref|WP_023185565.1|	32.5	237	328	648	5.97e-22	95.5
k99_152307_3	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	30.9	220	328	255	8.58e-22	91.7
k99_152307_3	SARG|gi|657888313|ref|WP_029592374.1|	32.1	262	328	648	1.08e-21	94.7
k99_152307_3	SARG|gi|639216333|ref|WP_024554080.1|	32.0	244	328	648	1.46e-21	94.4
k99_152307_3	SARG|gi|896325272|ref|WP_049294291.1|	31.6	244	328	648	4.82e-21	92.8
k99_152307_3	SARG|gi|507086196|ref|WP_016156937.1|	30.3	238	328	648	6.49e-21	92.4
k99_152307_3	SARG|gi|757799695|ref|WP_043016897.1|	30.3	238	328	648	8.75e-21	92.0
k99_152307_3	SARG|gi|1045891604|ref|WP_065554100.1|	30.3	238	328	648	8.75e-21	92.0
k99_152307_3	SARG|gi|639225329|ref|WP_024561799.1|	31.3	252	328	648	8.75e-21	92.0
k99_152307_3	SARG|gi|507082903|ref|WP_016153652.1|	30.3	238	328	648	8.75e-21	92.0
k99_152307_4	SARG|gb|AAK76137.1|ARO:3000024|patA	29.5	234	335	564	1.63e-15	76.3
k99_158547_1	CARD|gb|ALH22601.1|ARO:3000620|adeL	37.1	178	224	337	1.85e-29	111
k99_159667_2	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	34.2	848	805	703	8.80e-136	418
k99_159667_14	SARG|B7NF27	99.5	391	392	391	1.60e-267	726
k99_159667_14	SARG|YP_002331481	99.5	391	392	391	1.60e-267	726
k99_159667_14	SARG|gi|727765868|ref|WP_033870271.1|	99.2	391	392	391	2.27e-267	726
k99_159667_14	SARG|A1AHP3	99.2	391	392	391	4.57e-267	725
k99_159667_14	SARG|gi|653702776|ref|WP_027662663.1|	99.2	391	392	391	6.50e-267	724
k99_159667_14	SARG|B1LL36	99.2	391	392	391	9.23e-267	724
k99_159667_14	SARG|gi|544581398|ref|WP_021038195.1|	99.0	391	392	391	9.23e-267	724
k99_159667_14	SARG|gi|754650824|ref|WP_042034967.1|	99.0	391	392	391	1.31e-266	724
k99_159667_14	SARG|gi|486772027|ref|WP_001620939.1|	99.0	391	392	391	1.86e-266	723
k99_159667_14	SARG|YP_671782	99.0	391	392	391	5.33e-266	722
k99_161390_13	NCBI|WP_063844229.1|1|1|cmlV|cmlV|efflux|2|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_MFS_transporter_CmlV|AMR|phenicol	27.0	389	423	412	3.65e-37	139
k99_161390_13	SARG|U09991.1.gene2.p01	27.0	389	423	436	5.44e-37	139
k99_161390_13	SARG|AF015087.1.gene1.p01	26.1	356	423	391	1.58e-33	128
k99_161390_13	megares|MEG_1780|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	26.1	352	423	391	4.14e-33	127
k99_161390_13	SARG|gi|2708772|gb|AAB96371.1|	25.6	391	423	391	2.27e-29	117
k99_161390_13	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	23.1	386	423	391	5.86e-29	115
k99_161390_13	SARG|NP_044444	25.6	391	423	391	5.86e-29	115
k99_161390_13	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	23.0	382	423	391	1.51e-28	114
k99_161390_13	SARG|AF024666.2.gene33.p01	25.3	391	423	391	1.51e-28	114
k99_161390_13	SARG|YP_251195	25.3	391	423	391	2.84e-28	114
k99_164527_4	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	27.5	222	253	579	1.55e-11	62.8
k99_164527_4	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	26.6	222	253	579	1.24e-10	60.1
k99_164527_4	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.9	218	253	655	1.02e-09	57.4
k99_164527_4	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.9	218	253	655	1.02e-09	57.4
k99_164527_4	SARG|gb|CDO61516.1|ARO:3003949|efrB	22.9	157	253	362	4.49e-09	55.1
k99_164527_4	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	7.99e-09	54.7
k99_164527_4	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.07e-08	54.3
k99_164527_4	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.07e-08	54.3
k99_164527_4	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.07e-08	54.3
k99_164527_4	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.07e-08	54.3
k99_165909_1	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	60.9	220	205	374	3.63e-84	253
k99_165909_1	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	57.1	170	205	357	1.52e-59	189
k99_168597_2	CARD|gb|AAC16242.1|ARO:3005069|rsmA	85.2	61	62	61	4.58e-31	101
k99_169941_1	SARG|gi|504542119|ref|WP_014729221.1|	38.8	255	251	647	8.29e-46	160
k99_169941_1	SARG|gi|565651791|ref|WP_023899061.1|	39.6	255	251	647	8.29e-46	160
k99_169941_1	SARG|gi|742384718|ref|WP_038863845.1|	41.4	237	251	647	3.03e-45	159
k99_169941_1	SARG|gi|742409107|ref|WP_038888226.1|	41.8	237	251	647	3.03e-45	159
k99_169941_1	SARG|gi|938460528|ref|WP_054624864.1|	39.1	256	251	647	3.03e-45	159
k99_169941_1	SARG|gi|742378414|ref|WP_038857601.1|	38.4	255	251	647	3.03e-45	159
k99_169941_1	SARG|gi|938461734|ref|WP_054625806.1|	38.4	255	251	647	4.19e-45	159
k99_169941_1	SARG|gi|1020141879|ref|WP_063264839.1|	38.4	255	251	647	4.19e-45	159
k99_169941_1	SARG|gi|490522515|ref|WP_004387938.1|	38.4	255	251	647	4.19e-45	159
k99_169941_1	SARG|YP_001438541	38.4	255	251	647	5.78e-45	158
k99_170807_1	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	32.9	149	388	639	1.76e-13	70.9
k99_175492_9	SARG|gb|AYV52072.1|ARO:3002882|lmrD	25.8	217	249	664	1.58e-14	71.6
k99_175492_9	SARG|gi|446048013|ref|WP_000125868.1|	26.5	226	249	648	2.32e-09	56.2
k99_175492_9	SARG|gi|974588181|ref|WP_059178476.1|	26.4	193	249	646	4.18e-09	55.5
k99_175492_9	SARG|YP_001176128	26.4	193	249	646	4.18e-09	55.5
k99_185423_2	SARG|gi|446048013|ref|WP_000125868.1|	33.7	104	371	648	1.49e-11	64.7
k99_185423_2	SARG|gi|654544841|ref|WP_028012549.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|829908959|ref|WP_047362283.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|1015876944|ref|WP_062856780.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|504644166|ref|WP_014831268.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|522181382|ref|WP_020689930.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|896106549|ref|WP_049136608.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|829942568|ref|WP_047368199.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|1006477526|ref|WP_061771940.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_2	SARG|gi|742827468|ref|WP_038984467.1|	35.4	99	371	646	8.24e-11	62.4
k99_185423_9	NCBI|WP_063856758.1|1|1|vanTc2|vanTc2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	33.8	370	360	706	1.68e-44	161
k99_185423_9	NCBI|WP_063856759.1|1|1|vanTc3|vanTc3|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	34.1	370	360	700	2.21e-44	161
k99_185423_9	NCBI|WP_063856756.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	33.5	367	360	700	2.02e-43	158
k99_185423_9	SARG|gb|ABA71733.1|ARO:3002972|vanTG	31.1	363	360	712	3.00e-43	158
k99_185423_9	NCBI|WP_063856755.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	33.1	369	360	700	1.34e-42	156
k99_185423_9	SARG|JF802084.2.gene3.p01	30.6	359	360	700	4.73e-42	154
k99_185423_9	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	32.0	362	360	366	3.88e-41	147
k99_185423_9	SARG|FJ872411.1.gene43.p01	32.4	364	360	702	4.31e-41	152
k99_185423_9	SARG|gi|498467693|ref|WP_010773049.1|	32.0	366	360	700	3.81e-40	149
k99_185423_9	SARG|AF162694.1.gene4.p01	31.3	361	360	698	1.32e-39	147
k99_185827_11	CARD|gb|AAK37618.1|ARO:3005008|TxR	32.4	315	514	318	9.87e-48	167
k99_200023_3	CARD|gb|BAB35162.1|ARO:3000676|H-NS	96.3	107	118	137	9.46e-58	174
